10,000 Matching Annotations
  1. Oct 2026
    1. The patient is a boy of Estonian and Spanish origin with early-onset muscular hypotonia and delayed motor development.

      Case#: proband, young boy

      DiseaseAssertion: muscular hypotonia

      CasePresentingHPOs: HP:0008947, HP:0008947, HP:0002421, HP:0006829, HP:0008994, HP:0008981

      "Infantile muscular hypotonia, delayed motor development, poor head control, severe muscular hypotonia, proximal muscle weakness in lower limbs, calf muscle hypertrophy"

      CasePreviousTesting: ENMG at 3.5 months interpreted as normal, but at 6 months showed features of myopathy or muscular dystrophy

      GenotypingMethod: Whole exome sequencing (WES) of the parents-offspring trio, Mutation was confirmed as de novo with Sanger sequencing. In silico analysis using both MutationTaster and MutPred Splice predicted the variant to disrupt splicing

      Variant: NM_000257.4:c.5655G>A

      ClinVar: 378215

      CAID: CA16606815

      gnomAD: https://gnomad.broadinstitute.org/variant/14-23883216-C-T

      Total Allele Frequency: 0.00001193 European (non-Finnish): 0.00002637

    1. Supplementary Data: Online Table 1a

      Case:

      CasePreviousTesting: Full sarcomere testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CRYAB, CSRP3, DES, DMD, DSC2, DSG2, DSP, EMD, GLA, JPH2, JUP, LAMA4, LAMP2, LMNA, MYH6, MYPN, MYOZ1, MYOZ2, PKP2, PLN, PRKAG2, RBM20, RYR2, SCN5A, SGCD, TAZ, TCAP, TMEM43, TNNC1, TTN, VCL and LDB3)

      CaseGenotypingMethod: DNA isolated from peripheral blood, targeted enrichment, next-gen sequencing with panel of 46 genes

      Variant: NM_000257.3:c.5773C>G

      CAID: CA257807342, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA257807342

      gnomAD: n/a

    2. Supplementary Data: Online Table 2a

      Case:

      CasePresentingHPOs: HP:0010316, HP:0001645 (Ebstein anomaly, sudden cardiac death)

      CasePreviousTesting: Full sarcomere testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CRYAB, CSRP3, DES, DMD, DSC2, DSG2, DSP, EMD, GLA, JPH2, JUP, LAMA4, LAMP2, LMNA, MYH6, MYPN, MYOZ1, MYOZ2, PKP2, PLN, PRKAG2, RBM20, RYR2, SCN5A, SGCD, TAZ, TCAP, TMEM43, TNNC1, TTN, VCL and LDB3)

      CaseGenotypingMethod: DNA isolated from peripheral blood, targeted enrichment, next-gen sequencing with panel of 46 genes

      Variant: NM_000257.3:c.5754C>G

      CAID: CA389034544, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA389034544

      gnomAD: n/a

    3. Supplementary Data: Online Table 2a

      Case:

      CasePreviousTesting: Full sarcomere testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CRYAB, CSRP3, DES, DMD, DSC2, DSG2, DSP, EMD, GLA, JPH2, JUP, LAMA4, LAMP2, LMNA, MYH6, MYPN, MYOZ1, MYOZ2, PKP2, PLN, PRKAG2, RBM20, RYR2, SCN5A, SGCD, TAZ, TCAP, TMEM43, TNNC1, TTN, VCL and LDB3)

      CaseGenotypingMethod: DNA isolated from peripheral blood, targeted enrichment, next-gen sequencing with panel of 46 genes

      Variant: NM_000257.3(MYH7):c.732+1G>A

      ClinVar: 14127, https://www.ncbi.nlm.nih.gov/clinvar/variation/14127/

      gnomAD: 0.000003976, https://gnomad.broadinstitute.org/variant/14-23900793-C-T

    4. Supplementary Data: Online Table 2a

      Case:

      CasePreviousTesting: Full sarcomere testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CRYAB, CSRP3, DES, DMD, DSC2, DSG2, DSP, EMD, GLA, JPH2, JUP, LAMA4, LAMP2, LMNA, MYH6, MYPN, MYOZ1, MYOZ2, PKP2, PLN, PRKAG2, RBM20, RYR2, SCN5A, SGCD, TAZ, TCAP, TMEM43, TNNC1, TTN, VCL and LDB3)

      CaseGenotypingMethod: DNA isolated from peripheral blood, targeted enrichment, next-gen sequencing with panel of 46 genes

      Variant: NM_000257.3:c.415G>T

      CAID: CA389052864, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA389052864

      gnomAD: n/a

    5. Supplementary Data: Online Table 1a

      Case:

      CasePreviousTesting: Full sarcomere testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CRYAB, CSRP3, DES, DMD, DSC2, DSG2, DSP, EMD, GLA, JPH2, JUP, LAMA4, LAMP2, LMNA, MYH6, MYPN, MYOZ1, MYOZ2, PKP2, PLN, PRKAG2, RBM20, RYR2, SCN5A, SGCD, TAZ, TCAP, TMEM43, TNNC1, TTN, VCL and LDB3)

      CaseGenotypingMethod: DNA isolated from peripheral blood, targeted enrichment, next-gen sequencing with panel of 46 genes

      Variant: NM_000257.3(MYH7):c.728G>A (p.Arg243His)

      ClinVar: 14126, https://www.ncbi.nlm.nih.gov/clinvar/variation/14126/

      gnomAD: 0.000007953, https://gnomad.broadinstitute.org/variant/14-23900798-C-T

    6. Supplementary Data: Online Table 2a

      Case:

      CasePreviousTesting: Full sarcomere testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CRYAB, CSRP3, DES, DMD, DSC2, DSG2, DSP, EMD, GLA, JPH2, JUP, LAMA4, LAMP2, LMNA, MYH6, MYPN, MYOZ1, MYOZ2, PKP2, PLN, PRKAG2, RBM20, RYR2, SCN5A, SGCD, TAZ, TCAP, TMEM43, TNNC1, TTN, VCL and LDB3)

      CaseGenotypingMethod: DNA isolated from peripheral blood, targeted enrichment, next-gen sequencing with panel of 46 genes

      Variant: NM_000257.3:c.3100-2A>C

      CAID: CA035633, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA035633

      gnomAD: 0.00002475, https://gnomad.broadinstitute.org/variant/14-23891536-T-G

    7. Supplementary Data: Online Table 2a

      Case:

      CasePreviousTesting: Full sarcomere testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CRYAB, CSRP3, DES, DMD, DSC2, DSG2, DSP, EMD, GLA, JPH2, JUP, LAMA4, LAMP2, LMNA, MYH6, MYPN, MYOZ1, MYOZ2, PKP2, PLN, PRKAG2, RBM20, RYR2, SCN5A, SGCD, TAZ, TCAP, TMEM43, TNNC1, TTN, VCL and LDB3)

      CaseGenotypingMethod: DNA isolated from peripheral blood, targeted enrichment, next-gen sequencing with panel of 46 genes

      Variant: NM_000257.3:c.1915A>G

      CAID: CA389049545, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA389049545

      gnomAD: n/a

    8. Supplementary Data: Online Table 1a

      Case:

      CasePreviousTesting: Full sarcomere testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CRYAB, CSRP3, DES, DMD, DSC2, DSG2, DSP, EMD, GLA, JPH2, JUP, LAMA4, LAMP2, LMNA, MYH6, MYPN, MYOZ1, MYOZ2, PKP2, PLN, PRKAG2, RBM20, RYR2, SCN5A, SGCD, TAZ, TCAP, TMEM43, TNNC1, TTN, VCL and LDB3)

      CaseGenotypingMethod: DNA isolated from peripheral blood, targeted enrichment, next-gen sequencing with panel of 46 genes

      Variant: NM_000257.3(MYH7):c.1106G>A (p.Arg369Gln)

      ClinVar: 42822, https://www.ncbi.nlm.nih.gov/clinvar/variation/42822/

      gnomAD: n/a

    9. Supplementary Data: Online Table 3

      Case:

      CasePreviousTesting: Full sarcomere testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CRYAB, CSRP3, DES, DMD, DSC2, DSG2, DSP, EMD, GLA, JPH2, JUP, LAMA4, LAMP2, LMNA, MYH6, MYPN, MYOZ1, MYOZ2, PKP2, PLN, PRKAG2, RBM20, RYR2, SCN5A, SGCD, TAZ, TCAP, TMEM43, TNNC1, TTN, VCL and LDB3)

      CaseGenotypingMethod: DNA isolated from peripheral blood, targeted enrichment, next-gen sequencing with panel of 46 genes

      Variant: NM_000257.3:c.3928C>G

      CAID: CA389041570, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA389041570

      gnomAD: n/a

    1. Supplementary Data: S2 Table

      Case 95: Spanish, 1yo, Female

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      CasePreviousTesting: Full Testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data table S1

      CaseGenotypingMethod: genomic DNA obtained from blood or saliva, Next-gen sequencing panels of 55 or 78 genes

      Variant: NM_000257.3(MYH7):c.2608C>T (p.Arg870Cys)

      ClinVar: 161326, https://www.ncbi.nlm.nih.gov/clinvar/variation/161326/

      gnomAD: 0.00002386, https://gnomad.broadinstitute.org/variant/14-23894049-G-A

      MultipleGeneVariants:

      (1) TTN Variant:

      Variant: NM_133378.4:c.8920A>G

      CAID: CA61002480, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_133378.4%3Ac.8920A%3EG

      gnomAD: n/a

    2. Supplementary Data: S2 Table

      Case 236: Spanish, 37yo, Male

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      CasePreviousTesting: Full Testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data table S1

      CaseGenotypingMethod: genomic DNA obtained from blood or saliva, Next-gen sequencing panels of 55 or 78 genes

      Variant1: NM_000257.3(MYH7):c.4954G>T (p.Asp1652Tyr)

      ClinVar: 43047, https://www.ncbi.nlm.nih.gov/clinvar/variation/43047/

      gnomAD: 0.00004774, https://gnomad.broadinstitute.org/variant/14-23885041-C-A

      Variant2: NM_000257.3(MYH7):c.4817G>A (p.Arg1606His)

      ClinVar: 43039, https://www.ncbi.nlm.nih.gov/clinvar/variation/43039/

      gnomAD: 0.00003889, https://gnomad.broadinstitute.org/variant/14-23885349-C-T

    3. Supplementary Data: S2 Table

      Case 116: Spanish, 66yo, Female

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      CasePreviousTesting: Full Testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data table S1

      CaseGenotypingMethod: genomic DNA obtained from blood or saliva, Next-gen sequencing panels of 55 or 78 genes

      Variant: NM_000257.3(MYH7):c.2167C>G (p.Arg723Gly)

      ClinVar: 42885, https://www.ncbi.nlm.nih.gov/clinvar/variation/42885/

      gnomAD: n/a

      MultipleGeneVariants

      (1) TTN Variant:

      Variant: NM_133378.4:c.31738G>A

      CAID: CA349484668, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_133378.4%3Ac.31738G%3EA

      gnomAD: n/a

      (2) MYBPC3 Variant:

      Variant: NM_000256.3(MYBPC3):c.3676C>T (p.Arg1226Cys)

      ClinVar: 42731, https://www.ncbi.nlm.nih.gov/clinvar/variation/42731/

      gnomAD: 0.00004815, https://gnomad.broadinstitute.org/variant/11-47353761-G-A

    4. Supplementary Data: S2 Table

      Case 1: Spanish, 42yo, Male

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      CasePreviousTesting: Full Testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data table S1

      CaseGenotypingMethod: genomic DNA obtained from blood or saliva, PCR, Sanger Sequencing

      Variant: NM_000257.3(MYH7):c.427C>T (p.Arg143Trp)

      ClinVar: 164401, https://www.ncbi.nlm.nih.gov/clinvar/variation/164401/

      gnomAD: 0.00002784, https://gnomad.broadinstitute.org/variant/14-23901923-G-A

    5. Supplementary Data: S2 Table

      Case 195: Spanish, 53yo, Female

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      CasePreviousTesting: Full Testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data table S1

      CaseGenotypingMethod: genomic DNA obtained from blood or saliva, Next-gen sequencing panels of 55 or 78 genes

      Variant: NM_000257.3(MYH7):c.958G>A (p.Val320Met)

      ClinVar: 161328, https://www.ncbi.nlm.nih.gov/clinvar/variation/161328/

      gnomAD: 0.00001591, https://gnomad.broadinstitute.org/variant/14-23899810-C-T

    6. Supplementary Data: S2 Table

      Case 47: Spanish, 40yo, Male

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      CasePreviousTesting: Full Testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data table S1

      CaseGenotypingMethod: genomic DNA obtained from blood or saliva, Next-gen sequencing panels of 55 or 78 genes

      Variant: NM_000257.3(MYH7):c.4066G>A (p.Glu1356Lys)

      ClinVar: 164294, https://www.ncbi.nlm.nih.gov/clinvar/variation/164294/

      gnomAD: n/a

    1. Supplementary Data Table S3

      Case: 62

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3158G>A (p.Arg1053Gln)

      ClinVar: 155814, https://www.ncbi.nlm.nih.gov/clinvar/variation/155814/

      gnomAD: 0.00006010, https://gnomad.broadinstitute.org/variant/14-23891476-C-T

      MultipleGeneVariants:

      (1) LMNA Variant

      Variant: NM_001282625.1:c.1551G>T

      CAID: CA342823303, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA342823303

      gnomAD: 0.00001100, https://gnomad.broadinstitute.org/variant/1-156106966-G-T

      (2) RBM20 Variant

      Variant: NM_001134363.3(RBM20):c.2662G>A (p.Asp888Asn)

      ClinVar: 43995, https://www.ncbi.nlm.nih.gov/clinvar/variation/43995/

      gnomAD: 0.004046, https://gnomad.broadinstitute.org/variant/10-112581039-G-A

    2. Supplementary Data Table S3

      Case: 194

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.2770G>A (p.Glu924Lys)

      ClinVar: 14092 https://www.ncbi.nlm.nih.gov/clinvar/variation/14092/

      gnomAD: Not in gnomAD

      MultipleGeneVariants:

      (1) DES Variant

      Variant: NM_001927.4(DES):c.137C>T (p.Ser46Phe)

      ClinVar: 66406 https://www.ncbi.nlm.nih.gov/clinvar/variation/66406/

      gnomAD: Not in gnomAD

      (2) MYH6 Variant

      Variant: NM_002471.3:c.5209A>T (p.Thr1737Ser)

      CAID: CA257777730 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA257777730

      gnomAD: Not in gnomAD

      (3) TNNT2 Variant

      Variant: NM_000364.3:c.416G>A (p.Arg139Lys)

      CAID: CA028406 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA028406

      gnomAD: Not in gnomAD

    3. Supplementary Data Table S3

      Case: 17

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3158G>A (p.Arg1053Gln)

      ClinVar: 155814, https://www.ncbi.nlm.nih.gov/clinvar/variation/155814/

      gnomAD: 0.00006010, https://gnomad.broadinstitute.org/variant/14-23891476-C-T

      MultipleGeneVariants:

      (1) NEBL Variant

      Variant: NM_006393.2(NEBL):c.2054C>T (p.Ala685Val)

      ClinVar: 227732, https://www.ncbi.nlm.nih.gov/clinvar/variation/227732/

      gnomAD: 0.0003290, https://gnomad.broadinstitute.org/variant/10-21108354-G-A

      (2) RBM20 Variant

      Variant: NM_001134363.3(RBM20):c.2662G>A (p.Asp888Asn)

      ClinVar: 43995, https://www.ncbi.nlm.nih.gov/clinvar/variation/43995/

      gnomAD: 0.004046, https://gnomad.broadinstitute.org/variant/10-112581039-G-A

    4. Supplementary Data Table S3

      Case: 212

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3158G>A (p.Arg1053Gln)

      ClinVar: 155814 https://www.ncbi.nlm.nih.gov/clinvar/variation/155814/

      gnomAD: 0.0006368, https://gnomad.broadinstitute.org/variant/14-23891476-C-T

      MultipleGeneVariants:

      (1) PLB1 Variant

      Variant: NM_153021.4:c.2981C>G (p.Ser994Cys)

      CAID: CA1588372 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_153021.5%3Ac.2981C%3EG

      gnomAD: 0.0002632, http://gnomad.broadinstitute.org/variant/2-28828739-C-G

      (2) SCN5A Variant

      Variant: NM_000335.4(SCN5A):c.1715C>A (p.Ala572Asp)

      ClinVar: 67683 https://www.ncbi.nlm.nih.gov/clinvar/variation/67683/

      gnomAD: 0.03855, https://gnomad.broadinstitute.org/variant/3-38645378-G-T

    5. Supplementary Data Table S3

      Case: 282

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.4901G>A (p.Arg1634His)

      ClinVar: 222730 https://www.ncbi.nlm.nih.gov/clinvar/variation/222730/

      gnomAD: Not in gnomAD

      MultipleGeneVariants:

      (1) DSP Variant

      Variant: NM_004415.4(DSP):c.1348C>G (p.Pro450Ala)

      ClinVar: 222572 https://www.ncbi.nlm.nih.gov/clinvar/variation/222572/

      gnomAD: Not in gnomAD

      (2) DSP Variant

      Variant: NM_004415.4(DSP):c.6208G>A (p.Asp2070Asn)

      ClinVar: 44936 https://www.ncbi.nlm.nih.gov/clinvar/variation/44936/

      gnomAD: 0.007910, https://gnomad.broadinstitute.org/variant/6-7583703-G-A

      (3) GAL Variant

      Variant: NM_015973.5(GAL):c.47C>T (p.Ala16Val)

      ClinVar: 475915 https://www.ncbi.nlm.nih.gov/clinvar/variation/475915/

      gnomAD: 0.01730, https://gnomad.broadinstitute.org/variant/11-68452438-C-T

      (4) MYBPC3 Variant

      Variant: NM_000256.3(MYBPC3):c.2686G>A (p.Val896Met)

      ClinVar: 42652 https://www.ncbi.nlm.nih.gov/clinvar/variation/42652/

      gnomAD: 0.02794, https://gnomad.broadinstitute.org/variant/11-47357479-C-T

      (5) PLB1 Variant

      Variant: NM_153021.4:c.275A>G (p.Lys92Arg)

      CAID: CA1586810 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_153021.5%3Ac.275A%3EG

      gnomAD: 0.03209, https://gnomad.broadinstitute.org/variant/2-28748165-A-G

    6. Supplementary Data Table S3

      Case: 107

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.1178C>T (p.Ala393Val)

      ClinVar: 222721 https://www.ncbi.nlm.nih.gov/clinvar/variation/222721/

      gnomAD: Not in gnomAD

      MultipleGeneVariants:

      (1) DSP Variant

      Variant: NM_004415.4(DSP):c.5498A>T (p.Glu1833Val)

      ClinVar: 44929 https://www.ncbi.nlm.nih.gov/clinvar/variation/44929/

      gnomAD: 0.02491, https://gnomad.broadinstitute.org/variant/6-7582993-A-T

      (2) FHL2 Variant

      Variant: NM_201555.1:c.-144C>T

      CAID: CA1814921 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA1814921

      gnomAD: 0.01323 https://gnomad.broadinstitute.org/variant/2-106006683-G-A

    7. Supplementary Data Table S3

      Case: 23

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3158G>A (p.Arg1053Gln)

      ClinVar: 155814, https://www.ncbi.nlm.nih.gov/clinvar/variation/155814/

      gnomAD: 0.00006010, https://gnomad.broadinstitute.org/variant/14-23891476-C-T

    8. Supplementary Data Table S3

      Case: 67

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3158G>A (p.Arg1053Gln)

      ClinVar: 155814 https://www.ncbi.nlm.nih.gov/clinvar/variation/155814/

      gnomAD: 0.0006368, https://gnomad.broadinstitute.org/variant/14-23891476-C-T

    9. Supplementary Data Table S3

      Case: 20

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.2155C>T (p.Arg719Trp)

      ClinVar: 14104, https://www.ncbi.nlm.nih.gov/clinvar/variation/14104/

      gnomAD: 0.00003185, https://gnomad.broadinstitute.org/variant/14-23895180-G-A

      MultipleGeneVariants:

      (1) LDB3 Variant

      Variant: NM_007078.3(LDB3):c.295C>T (p.Pro99Ser)

      ClinVar: 178059, https://www.ncbi.nlm.nih.gov/clinvar/variation/178059/

      gnomAD: 0.0009830, https://gnomad.broadinstitute.org/variant/10-88439888-C-T

      (2) RBM20 Variant

      Variant: NM_001134363.3(RBM20):c.2662G>A (p.Asp888Asn)

      ClinVar: 43995, https://www.ncbi.nlm.nih.gov/clinvar/variation/43995/

      gnomAD: 0.004046, https://gnomad.broadinstitute.org/variant/10-112581039-G-A

    10. Supplementary Data Table S3

      Case: 333

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3158G>A (p.Arg1053Gln)

      ClinVar: 155814 https://www.ncbi.nlm.nih.gov/clinvar/variation/155814/

      gnomAD: 0.0006368, https://gnomad.broadinstitute.org/variant/14-23891476-C-T

      MultipleGeneVariants:

      (1) RBM20 Variant

      Variant: NM_001134363.3(RBM20):c.2662G>A (p.Asp888Asn)

      ClinVar: 43995 https://www.ncbi.nlm.nih.gov/clinvar/variation/43995/

      gnomAD: 0.02090, https://gnomad.broadinstitute.org/variant/10-112581039-G-A

      (2) SDHA Variant

      Variant: NM_004168.4(SDHA):c.1886A>T (p.Tyr629Phe)

      ClinVar: 224949 https://www.ncbi.nlm.nih.gov/clinvar/variation/224949/

      gnomAD: 0.5249, https://gnomad.broadinstitute.org/variant/5-254599-A-T

    11. Supplementary Data Table S3

      Case: 22

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant 1: NM_000257.4(MYH7):c.1816G>A (p.Val606Met)

      ClinVar: 14091, https://www.ncbi.nlm.nih.gov/clinvar/variation/14091/

      gnomAD: 0.000007070, https://gnomad.broadinstitute.org/variant/14-23896866-C-T

      Variant 2: NM_000257.4(MYH7):c.3853+7C>T

      ClinVar: 42977, https://www.ncbi.nlm.nih.gov/clinvar/variation/42977/

      gnomAD: 0.002253, https://gnomad.broadinstitute.org/variant/14-23888685-G-A

    12. Supplementary Data Table S3

      Case: 276

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.1816G>A (p.Val606Met)

      ClinVar: 14091 https://www.ncbi.nlm.nih.gov/clinvar/variation/14091/

      gnomAD: 0.00001548, https://gnomad.broadinstitute.org/variant/14-23896866-C-T

      MultipleGeneVariants:

      (1) LAMA4 Variant

      Variant: NM_001105206.3(LAMA4):c.3239G>A (p.Arg1080Gln)

      ClinVar: 44374 https://www.ncbi.nlm.nih.gov/clinvar/variation/44374/

      gnomAD: 0.02400, https://gnomad.broadinstitute.org/variant/6-112460365-C-T

      (2) NEBL Variant

      Variant: NM_006393.2(NEBL):c.109_110del (p.Leu37fs)

      ClinVar: 229042 https://www.ncbi.nlm.nih.gov/clinvar/variation/229042/

      gnomAD: 0.001673, https://gnomad.broadinstitute.org/variant/10-21185929-TAA-T

    13. Supplementary Data Table S3

      Case: 90

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3158G>A (p.Arg1053Gln)

      ClinVar: 155814 https://www.ncbi.nlm.nih.gov/clinvar/variation/155814/

      gnomAD: 0.0006368, https://gnomad.broadinstitute.org/variant/14-23891476-C-T

      MultipleGeneVariants:

      (1) MYBPC3 Variant

      Variant: NM_000256.3(MYBPC3):c.977G>A (p.Arg326Gln)

      ClinVar: 42813 https://www.ncbi.nlm.nih.gov/clinvar/variation/42813/

      gnomAD: 0.01364, https://gnomad.broadinstitute.org/variant/11-47367871-C-T

    14. Supplementary Data Table S3

      Case: 218

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.2539_2541del (p.Lys847del)

      ClinVar: 42913 https://www.ncbi.nlm.nih.gov/clinvar/variation/42913/

      gnomAD: Not in gnomAD

      MultipleGeneVariants:

      (1) MYBPC3 Variant

      Variant: NM_000256.3(MYBPC3):c.2686G>A (p.Val896Met)

      ClinVar: 42652 https://www.ncbi.nlm.nih.gov/clinvar/variation/42652/

      gnomAD: 0.02794, https://gnomad.broadinstitute.org/variant/11-47357479-C-T

      (2) PSEN1 Variant

      Variant: NM_000021.4(PSEN1):c.953A>G (p.Glu318Gly)

      ClinVar: 98094 https://www.ncbi.nlm.nih.gov/clinvar/variation/98094/

      gnomAD: 0.03394, https://gnomad.broadinstitute.org/variant/14-73673178-A-G

      (3) TMPO Variant

      Variant: NM_001032283.2(TMPO):c.859G>C (p.Ala287Pro)

      ClinVar: 43693 https://www.ncbi.nlm.nih.gov/clinvar/variation/43693/

      gnomAD: 0.04732, https://gnomad.broadinstitute.org/variant/12-98938295-G-C

    15. Supplementary Data Table S3

      Case: 26

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3158G>A (p.Arg1053Gln)

      ClinVar: 155814, https://www.ncbi.nlm.nih.gov/clinvar/variation/155814/

      gnomAD: 0.00006010, https://gnomad.broadinstitute.org/variant/14-23891476-C-T

      MultipleGeneVariants:

      (1) FBN1 Variant

      Variant: NM_000138.4(FBN1):c.3077T>C (p.Phe1026Ser)

      ClinVar: 199948, https://www.ncbi.nlm.nih.gov/clinvar/variation/199948/

      gnomAD: 0.0006449, https://gnomad.broadinstitute.org/variant/15-48782053-A-G

      (2) SDHA Variant

      Variant: NM_004168.4(SDHA):c.1886A>T (p.Tyr629Phe)

      ClinVar: 224949, https://www.ncbi.nlm.nih.gov/clinvar/variation/224949/

      gnomAD: 0.1547, https://gnomad.broadinstitute.org/variant/5-254599-A-T

    16. Supplementary Data Table S3

      Case: 245

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3158G>A (p.Arg1053Gln)

      ClinVar: 155814 https://www.ncbi.nlm.nih.gov/clinvar/variation/155814/

      gnomAD: 0.0006368, https://gnomad.broadinstitute.org/variant/14-23891476-C-T

      MultipleGeneVariants:

      (1) DES Variant

      Variant: NM_001927.4(DES):c.638C>T (p.Ala213Val)

      ClinVar: 44265 https://www.ncbi.nlm.nih.gov/clinvar/variation/44265/

      gnomAD: 0.01512, https://gnomad.broadinstitute.org/variant/2-220284876-C-T

      (2) JUP Variant

      Variant: NM_002230.4(JUP):c.1942G>A (p.Val648Ile)

      ClinVar: 45842 https://www.ncbi.nlm.nih.gov/clinvar/variation/45842/

      gnomAD: 0.01341, https://gnomad.broadinstitute.org/variant/17-39913771-C-T

      (3) TTN Variant

      Variant: NM_001267550.2(TTN):c.33501_33503AGA[6] (p.Glu11172dup)

      ClinVar: 46889 https://www.ncbi.nlm.nih.gov/clinvar/variation/46889/

      gnomAD: 0.01788, https://gnomad.broadinstitute.org/variant/2-179544685-C-CTCT

    17. Supplementary Data Table S3

      Case: 25

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3158G>A (p.Arg1053Gln)

      ClinVar: 155814, https://www.ncbi.nlm.nih.gov/clinvar/variation/155814/

      gnomAD: 0.00006010, https://gnomad.broadinstitute.org/variant/14-23891476-C-T

      MultipleGeneVariants:

      (1) GAL Variant

      Variant: NM_015973.5(GAL):c.47C>T (p.Ala16Val)

      ClinVar: 475915, https://www.ncbi.nlm.nih.gov/clinvar/variation/475915/

      gnomAD: 0.006938, https://gnomad.broadinstitute.org/variant/11-68452438-C-T

    18. Supplementary Data Table S3

      Case: 47

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3158G>A (p.Arg1053Gln)

      ClinVar: 155814, https://www.ncbi.nlm.nih.gov/clinvar/variation/155814/

      gnomAD: 0.00006010, https://gnomad.broadinstitute.org/variant/14-23891476-C-T

      MultipleGeneVariants:

      (1) DOLK Variant

      Variant: NM_014908.3(DOLK):c.1dup (p.Met1fs)

      ClinVar: 167006, https://www.ncbi.nlm.nih.gov/clinvar/variation/167006/

      gnomAD: 0.006541, https://gnomad.broadinstitute.org/variant/9-131709581-A-AT

    19. Supplementary Data Table S3

      Case: 373

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.3:c.4903A>G (p.Met1635Val)

      CAID: CA044177 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA044177

      gnomAD: 0.0005972, https://gnomad.broadinstitute.org/variant/14-23885263-T-C

      MultipleGeneVariants:

      (1) LMNA Variant

      Variant: NM_170707.4(LMNA):c.357C>T (p.Arg119=)

      ClinVar: 48062 https://www.ncbi.nlm.nih.gov/clinvar/variation/48062/

      gnomAD: 0.01294, https://gnomad.broadinstitute.org/variant/1-156100408-C-T

      (2) MYBPC3 Variant

      Variant: NM_000256.3(MYBPC3):c.3181C>T (p.Gln1061Ter)

      ClinVar: 42690 https://www.ncbi.nlm.nih.gov/clinvar/variation/42690/

      gnomAD: 0.0001913, https://gnomad.broadinstitute.org/variant/11-47355117-G-A

      (3) SCN5A Variant

      Variant: NM_000335.4(SCN5A):c.553G>A (p.Ala185Thr)

      ClinVar: 67996 https://www.ncbi.nlm.nih.gov/clinvar/variation/67996/

      gnomAD: 0.004251, https://gnomad.broadinstitute.org/variant/3-38662392-C-T

      (4) VCL Variant

      Variant: NM_014000.2(VCL):c.1535G>A (p.Arg512His)

      ClinVar: 450167 https://www.ncbi.nlm.nih.gov/clinvar/variation/450167/

      gnomAD: 0.0001973, https://gnomad.broadinstitute.org/variant/10-75854211-G-A

    20. Supplementary Data Table S3

      Case: 123

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.3158G>A (p.Arg1053Gln)

      ClinVar: 155814 https://www.ncbi.nlm.nih.gov/clinvar/variation/155814/

      gnomAD: 0.0006368, https://gnomad.broadinstitute.org/variant/14-23891476-C-T

      MultipleGeneVariants:

      (1) DES Variant

      Variant: NM_001927.4(DES):c.638C>T (p.Ala213Val)

      ClinVar: 44265 https://www.ncbi.nlm.nih.gov/clinvar/variation/44265/

      gnomAD: 0.01512, https://gnomad.broadinstitute.org/variant/2-220284876-C-T

      (2) RBM20 Variant

      Variant: NM_001134363.3(RBM20):c.2662G>A (p.Asp888Asn)

      ClinVar: 44265 https://www.ncbi.nlm.nih.gov/clinvar/variation/44265/

      gnomAD: 0.02090, https://gnomad.broadinstitute.org/variant/10-112581039-G-A

  2. www.jstage.jst.go.jp www.jstage.jst.go.jp
    1. IV-4

      Case IV-1: Female, 20mo, carrier with no clinical manifestation

      CaseHPOFreeText: interventricular septum = 4mm, posterior wall of left ventricle = 4mm, normal electrocardiogram

      CasePreviousTesting: same as proband

      CaseGenotypingMethod: same as proband

      Variant: NM_000257.3:c.1172A>C

      CAID: CA389051191, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA389051191

      gnomAD: n/a

    2. III-15 Male

      Case III-15: Male, 18yo, diagnosed at 16yo

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      CasePresentingHPOs: HP:0012250 (ST segment depression

      CaseHPOFreeText: abnormal Q wave, interventricular septum = 15mm, posterior wall of left ventricle = 9mm

      CaseNotHPOs: HP:0005135 (abnormal T wave)

      CaseNotHPOFreeText: no clinical manifestations

      CasePreviousTesting: same as proband

      CaseGenotypingMethod: same as proband

      Variant: NM_000257.3:c.1172A>C

      CAID: CA389051191, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA389051191

      gnomAD: n/a

    3. IV-1

      Case IV-1: Female, 10mo, carrier with no clinical manifestation

      CaseHPOFreeText: interventricular septum = 4mm, posterior wall of left ventricle = 4mm, normal electrocardiogram

      CasePreviousTesting: same as proband

      CaseGenotypingMethod: same as proband

      Variant: NM_000257.3:c.1172A>C

      CAID: CA389051191, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA389051191

      gnomAD: n/a

    1. Case Report

      Case: proband, 9mo at presentation

      DiseaseAssertion: Idiopathic dilated cardiomyopathy

      CasePresentingHPOs: HP:0001635, HP:0001695, HP:0001263, HP:0007018, HP:0007018, HP:0002059, HP:0031332 (congestive heart failure, cardiac arrest, global developmental delay, attention deficit, autism, cerebral atrophy, myocyte degeneration)

      CaseHPOFreeText: had transvenous pacemaker for complete heart block and left ventricular assist device, ABO-incompatible heart transplant at 1yo, walked at 2.5yo, sensory and behavioral deficits, suspected mitochondrial disorder

      FamilyInfo: Parents underwent Sanger Sequencing to confirm variant was de novo in proband (Fig. 2)

      CasePreviousTesting: MRI, metabolic evaluation, Full testing (MYPBC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (TruSight One Gene List)

      CaseGenotypingMethod: chromosomal microarray, trio analysis with fluorescent in situ hybridization, next-gen sequencing of 4813 genes (TruSight One Sequencing Panel), Sanger Sequencing

      Variant: NM_000257.3(MYH7):c.2513C>T (p.Pro838Leu) (previously reported as de novo, PMID: 18380764)

      ClinVar: 42910, https://www.ncbi.nlm.nih.gov/clinvar/variation/42910/

      gnomAD: n/a

      MultipleGeneVariants:

      (1) NRXN1 Variant:

      Variant: 181,000bp copy number loss within chr 2:6.3, build NCBI 37/hg19 (from position 51201593-51382885)

    1. CaseCM0934: Male, 6 years diagnosis, Japan, Asian

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001939 (Abnormality of metabolism/homeostasis)

      NotHPOsFreeText: Neuromuscular disease, Malformation syndromes

      CaseAddInfo: Positive family history of cardiomyopathy or sudden death, Proband found in Supplementary Table 2, Mother tested negative for the variant


      CasePreviousTesting: 8 patients with HCM and one with RCM were analyzed by NGS for the eight sarcomere-encoding genes and MYP.

      CaseGenotypingMethod: Probands were subject to PCR amplification and direct sequencing of 64 cardiomyopathy-associated genes, including the eight sarcomere-encoding genes. The variants were then filtered for rarity and tested for pathogenicity.


      Variant: NM_000257.3:c.1357C>T (p.Arg453Cys)

      ClinVar: 14089 https://www.ncbi.nlm.nih.gov/clinvar/variation/14089/

      gnomAD: Not in gnomAD

    2. CaseCM1762: Female, 12 years diagnosis, Japan, Asian

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001939 (Abnormality of metabolism/homeostasis)

      NotHPOsFreeText: Neuromuscular disease, Malformation syndromes

      CaseAddInfo: No family history of cardiomyopathy or sudden death, Proband found in Supplementary Table 2, Father shows positive for this variant with no symptoms while Mother shows negative for this variant with no symptoms


      CasePreviousTesting: 8 patients with HCM and one with RCM were analyzed by NGS for the eight sarcomere-encoding genes and MYP.

      CaseGenotypingMethod: Probands were subject to PCR amplification and direct sequencing of 64 cardiomyopathy-associated genes, including the eight sarcomere-encoding genes. The variants were then filtered for rarity and tested for pathogenicity.


      Variant: NM_000257.3:c.1845G>C (p.Lys615Asn)

      CAID: CA389049696 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000257.3%3Ac.1845G%3EC

      gnomAD: Not in gnomAD

    3. CaseCM1824: Female, 13 years diagnosis, Japan, Asian

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001939 (Abnormality of metabolism/homeostasis)

      NotHPOsFreeText: Neuromuscular disease, Malformation syndromes

      CaseAddInfo: Positive family history of cardiomyopathy or sudden death, Proband found in Supplementary Table 2, Father afflicted with HCM and also positive for same variant


      CasePreviousTesting: 8 patients with HCM and one with RCM were analyzed by NGS for the eight sarcomere-encoding genes and MYP.

      CaseGenotypingMethod: Probands were subject to PCR amplification and direct sequencing of 64 cardiomyopathy-associated genes, including the eight sarcomere-encoding genes. The variants were then filtered for rarity and tested for pathogenicity.


      Variant: NM_000257.3:c.2146G>A (p.Gly716Arg)

      ClinVar: 14105 https://www.ncbi.nlm.nih.gov/clinvar/variation/14105/

      gnomAD: Not in gnomAD

    4. CaseCM1811: Female, 15 years diagnosis, Japan, Asian

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001939 (Abnormality of metabolism/homeostasis)

      NotHPOsFreeText: Neuromuscular disease, Malformation syndromes

      CaseAddInfo: No family history of cardiomyopathy or sudden death, Proband found in Supplementary Table 2, Mother shows positive for this variant with no symptoms while Father shows negative for this variant with no symptoms


      CasePreviousTesting: 8 patients with HCM and one with RCM were analyzed by NGS for the eight sarcomere-encoding genes and MYP.

      CaseGenotypingMethod: Probands were subject to PCR amplification and direct sequencing of 64 cardiomyopathy-associated genes, including the eight sarcomere-encoding genes. The variants were then filtered for rarity and tested for pathogenicity.


      Variant: NM_000257.3:c.1988G>A (p.Arg663His)

      ClinVar: 42875 https://www.ncbi.nlm.nih.gov/clinvar/variation/42875/

      gnomAD: European (Non-Finnish) 3.097e-5, Overall 1.414e-5 https://gnomad.broadinstitute.org/variant/14-23896042-C-T

    1. Supplementary Data table 1

      Case:

      DiseaseAssertion: hypertrophic cardiomyopathy

      CaseHPOFreeText: maximal wall thickness (MWT) ≥15 mm

      CasePreviousTesting: Full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (TNNC1, CSRP3, TCAP, ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CAV3, CRYAB, CTNNA3, DES, DSC2, DSG2, DSP, EMD, FHL1, GLA, JPH2, JUP, LAMA4, LAMP2, LDB3, LMNA, MIB1, MYH6, MYOZ2, MYPN, NEXN, PKP2, PLN, PRDM16, PRKAG2, RBM20, SCN5A, TAZ, TMEM43, TNNC1, TTN, TTR, VCL), electrocardiography

      CaseGenotypingMethod: direct sequencing of all coding intron-exon boundaries of 12 genes (prior to 2012), next-generation sequencing (post 2012)

      Variant: NM_000257.3(MYH7):c.2104A>G (p.Ile702Val) listed in paper as p.Arg719Gln

      ClinVar: 217470, https://www.ncbi.nlm.nih.gov/clinvar/variation/217470/

      gnomAD: n/a

    1. Supplementary Data: Table S3

      Case 1:

      DiseaseAssertion: left ventricular noncompaction

      CasePresentingHPOs: HP:0030682 (left ventricular noncompaction)

      CaseHPOFreeText: >7yo, able to hold breath, non compacted segment = distinct 2-layered appearance of trabeculated and compacted myocardium, NC/C ratio > 2.3:1

      CasePreviousTesting: Cardiac MRI using 17-segment model of LV segmentation, ECG, transthoracic echocardiography, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data tables S1 and S2.

      CaseGenotypingMethod: WES, variant enrichment analysis

      Variant: NM_000257.3(MYH7):c.3286G>T (p.Asp1096Tyr)

      ClinVar: 42963, https://www.ncbi.nlm.nih.gov/clinvar/variation/42953/

      gnomAD: 0.0001414, https://gnomad.broadinstitute.org/variant/14-23890217-C-A

      MultipleGeneVariants:

      (1) ACTN2 Variant:

      Variant: NM_001103.3(ACTN2):c.893G>A (p.Arg298His)

      ClinVar: 43951, https://www.ncbi.nlm.nih.gov/clinvar/variation/43951/

      gnomAD: 0.0004457, https://gnomad.broadinstitute.org/variant/1-236902618-G-A

    2. Supplementary Data: Table S3

      Case 87:

      DiseaseAssertion: left ventricular noncompaction

      CasePresentingHPOs: HP:0030682 (left ventricular noncompaction)

      CaseHPOFreeText: >7yo, able to hold breath, non compacted segment = distinct 2-layered appearance of trabeculated and compacted myocardium, NC/C ratio > 2.3:1

      CasePreviousTesting: Cardiac MRI using 17-segment model of LV segmentation, ECG, transthoracic echocardiography, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data tables S1 and S2.

      CaseGenotypingMethod: WES, variant enrichment analysis

      Variant: NM_000257.3:c.332C>T

      CAID: CA389053057, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA389053057

      gnomAD: n/a

      MultipleGeneVariants:

      (1) DMD Variant:

      Variant: NM_004011.3:c.3062C>A

      CAID: CA10378350, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA10378350

      gnomAD: 0.0001133, https://gnomad.broadinstitute.org/variant/X-31893318-G-T

    3. Supplementary Data: Table S3

      Case 7:

      DiseaseAssertion: left ventricular noncompaction

      CasePresentingHPOs: HP:0030682 (left ventricular noncompaction)

      CaseHPOFreeText: >7yo, able to hold breath, non compacted segment = distinct 2-layered appearance of trabeculated and compacted myocardium, NC/C ratio > 2.3:1

      CasePreviousTesting: Cardiac MRI using 17-segment model of LV segmentation, ECG, transthoracic echocardiography, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data tables S1 and S2.

      CaseGenotypingMethod: WES, variant enrichment analysis

      Variant: NM_000257.3(MYH7):c.2890G>C (p.Val964Leu)

      ClinVar: 42938, https://www.ncbi.nlm.nih.gov/clinvar/variation/42938/

      gnomAD: 0.0004383, https://gnomad.broadinstitute.org/variant/14-23893148-C-G

      MultipleGeneVariants:

      (1) TTN Variant:

      Variant: p.Arg12731Ter no ClinVar or CAID

    1. DiseaseAssertion: Hypertrophic Cardiomyopathy

      VariantPreviousTesting: ACTC1, ACTN2, CSRP3, LAMP2, MYBPC3, MYH7, NEXN, PLN, TNNC1, TNNI3, TNNT2, TPM1, CAV3, GLA, MYL2, MYL3, MYOZ2, PRKAG2, and TTR were all tested via NGS.

      VariantGenotypingMethod: Next-generation sequencing panels were used to sequence and read the genetic information of the 760 HCM probands for variants within exons and in +/- 10 nucleotides within the flanking introns of the genes provided above. These variants were then interpreted and filtered for pathogenicity.

      VariantAddInfo: Seen in one HCM proband

      Variant: NM_000257.4(MYH7):c.1816G>A (p.Val606Met)

      ClinVarID: 14091 https://www.ncbi.nlm.nih.gov/clinvar/variation/14091/

      gnomAD: 0.00001548, http://gnomad.broadinstitute.org/variant/14-23896866-C-T

    2. DiseaseAssertion: Hypertrophic Cardiomyopathy

      VariantPreviousTesting: ACTC1, ACTN2, CSRP3, LAMP2, MYBPC3, MYH7, NEXN, PLN, TNNC1, TNNI3, TNNT2, TPM1, CAV3, GLA, MYL2, MYL3, MYOZ2, PRKAG2, and TTR were all tested via NGS.

      VariantGenotypingMethod: Next-generation sequencing panels were used to sequence and read the genetic information of the 760 HCM probands for variants within exons and in +/- 10 nucleotides within the flanking introns of the genes provided above. These variants were then interpreted and filtered for pathogenicity.

      VariantAddInfo: Seen in one HCM proband

      Variant: NM_000257.3:c.2714G>A (p.Cys905Tyr)

      CAID: CA389047298 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA389047298

      gnomAD: Not in gnomAD

    3. DiseaseAssertion: None

      VariantPreviousTesting: Some combination of ACTC1, ACTN2, CSRP3, LAMP2, MYBPC3, MYH7, NEXN, PLN, TNNC1, TNNI3, TNNT2, TPM1, ABCC9, CTF1, DES, EMD, LDB3, LMNA, MYH6, RBM20, SGCD, TAZ, TCAP, TTN, VCL, CAV3, GLA, MYL2, MYL3, MYOZ2, PRKAG2, TTR, DSC2, DSG2, DSP, JUP, PKP2, RYR2, TMEM43, CASQ2 and RYR2 were tested via NGS.

      VariantGenotypingMethod: Next-generation sequencing panels were used to sequence and read the genetic information of probands for variants within exons and in +/- 10 nucleotides within the flanking introns of the genes provided above. These variants were then interpreted and filtered for pathogenicity.

      Variant: NM_000257.4(MYH7):c.2945T>C (p.Met982Thr)

      ClinVar: 42941 https://www.ncbi.nlm.nih.gov/clinvar/variation/42941/

      gnomAD: 0.001416, http://gnomad.broadinstitute.org/variant/14-23892910-A-G

    4. DiseaseAssertion: Hypertrophic Cardiomyopathy

      VariantPreviousTesting: ACTC1, ACTN2, CSRP3, LAMP2, MYBPC3, MYH7, NEXN, PLN, TNNC1, TNNI3, TNNT2, TPM1, CAV3, GLA, MYL2, MYL3, MYOZ2, PRKAG2, and TTR were all tested via NGS.

      VariantGenotypingMethod: Next-generation sequencing panels were used to sequence and read the genetic information of the 760 HCM probands for variants within exons and in +/- 10 nucleotides within the flanking introns of the genes provided above. These variants were then interpreted and filtered for pathogenicity.

      VariantAddInfo: Seen in one HCM probands

      Variant: NM_000257.4(MYH7):c.958G>A (p.Val320Met)

      ClinVar: 161328 https://www.ncbi.nlm.nih.gov/clinvar/variation/161328/

      gnomAD: 0.00006154, http://gnomad.broadinstitute.org/variant/14-23899810-C-T

    5. DiseaseAssertion: Cardiomyopathy

      VariantPreviousTesting: ACTC1, ACTN2, CSRP3, LAMP2, MYBPC3, MYH7, NEXN, PLN, TNNC1, TNNI3, TNNT2, TPM1, ABCC9, CTF1, DES, EMD, LDB3, LMNA, MYH6, RBM20, SGCD, TAZ, TCAP, TTN, VCL, CAV3, GLA, MYL2, MYL3, MYOZ2, PRKAG2, TTR, DSC2, DSG2, DSP, JUP, PKP2, RYR2, TMEM43, CASQ2 and RYR2 were all tested in the PanCM panel.

      VariantGenotypingMethod: Next-generation sequencing panels were used to sequence and read the genetic information of the 305 PanCM probands for variants within exons and in +/- 10 nucleotides within the flanking introns of the genes provided above. These variants were then interpreted and filtered for pathogenicity.

      VariantAddInfo: Seen in two PanCM probands

      Variant: NM_000257.4(MYH7):c.4498C>T (p.Arg1500Trp)

      ClinVar: 164284 https://www.ncbi.nlm.nih.gov/clinvar/variation/164284/

      gnomAD: Not in gnomAD

    1. CasePT-80: United States

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001650, HP:0001658 (Aortic valve stenosis, Myocardial infarction)

      NotHPOsFreeText: N/A

      CaseAddInfo:


      CaseGenotypingMethod: DNA was collected from the participants using blood samples. 18 genes suspected on contributing to HCM were targeted and sequenced. The variants were then located and filtered for pathogenicity.


      Variant: NM_000257.3:c.2546T>C (p.Met849Thr)

      ClinVar: 42914 https://www.ncbi.nlm.nih.gov/clinvar/variation/42914/

      gnomAD: Not in gnomAD

    2. CasePT-35: United States

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001650, HP:0001658 (Aortic valve stenosis, Myocardial infarction)

      NotHPOsFreeText: N/A

      CaseAddInfo: PT-36 and PT-37 are the proband's siblings in Family 18 with the same genotype


      CaseGenotypingMethod: DNA was collected from the participants using blood samples. 18 genes suspected on contributing to HCM were targeted and sequenced. The variants were then located and filtered for pathogenicity.


      Variant: NM_000257.3:c.1491G>T (p.Glu497Asp)

      ClinVar: 14124 https://www.ncbi.nlm.nih.gov/clinvar/variation/14124/

      gnomAD: Ashkenazi Jewish 1.984e-4, Overall 7.953e-6 https://gnomad.broadinstitute.org/variant/14-23897796-C-A

    1. Clinical Case

      Case III-1: Male, 11yo, proband, died at 12yo

      DiseaseAssertion: Left ventricular hypertrophy

      CasePresentingHPOs: HP:0002018, HP:0000969, HP:0003388, HP:0001640, HP:0002240, HP:0002240, HP:0005135, HP:0031295 (nausea, edema, fatigability, cardiomegaly, hepatomegaly, left ventricular hypertrophy, abnormal T-wave, left atrial enlargement)

      CaseHPOFreeText: inability to lie down, double chambered left ventricle, protrusion of precordium, soft heart sounds, grade 3/6 systolic murmur at the cardiac apex, liver enlarged to 3cm below right costal margin, left ventricle divided into apical and basal chambers by an incomplete fibromuscular septum, basal chamber was enlarged (ball-shaped) and had end-diastolic diameter of 80.7mm, impaired contraction of of left ventricular wall and septum, reduction of left ventricular ejection fraction = 35%, diameter of communication between 2 chambers of left ventricle = 16.0mm, the apical chamber of the left ventricle had a thinning wall, relative dullness of cardiac enlargement, normal thickness of septum and left ventricular wall, upper and middle section of ventricular septum expanded to right ventricle, died due to multiple system organ failure

      FamilyInfo: 8 family members with double-chambered left ventricles

      CasePreviousTesting: transthoracic echocardiography, ECG, cardiac MRI

      CaseGenotypingMethod: WES, Affymetrix Cytoscan 750K Array to check potential candidate copy number variations, segregation analysis using the results from Sanger sequencing

      Variant: NM_000257.3:c.998A>T

      CAID: CA389051586, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA389051586

      gnomAD: n/a

    2. II-3

      Case II-3: Female, 40yo

      DiseaseAssertion: Left ventricular hypertrophy

      CasePresentingHPOs: HP:0001712 (left ventricular hypertrophy)

      CaseHPOFreeText: double-chambered left ventricle, reduced exercise capacity for 13yrs, mild heart failure symptoms, normal thickness of septum and left ventricle, 2 chambers of left ventricle have 18.5mm diameter of communication and they contract almost normally, left ventricle ventricle end-diastolic diameter = 74.3mm, left ventricular ejection fraction = 45%

      CasePreviousTesting: same as proband

      CaseGenotypingMethod: segregation analysis using the results from Sanger sequencing

      Variant: NM_000257.3:c.998A>T

      CAID: CA389051586, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA389051586

      gnomAD: n/a

    1. 2

      Case2: Male, 46 yrs onset, China, Asian

      DiseaseAssertion: Arrhythmogenic Cardiomyopathy

      FamilyInfo: Brother has ACM with dyskinesia and enlargement in RVOT and frequent VES, PKP2 variant segregated with disease but MYH7 variant was detected in 9 unaffected relatives (See Fig 3)

      CasePresentingHPOs: HP:0001638, HP:0011675, HP:0010872, HP:0011712, HP:0004756, HP:0001962, HP:0002321, HP:0006682, HP:0001707 (Cardiomyopathy, Arrhythmia, T-wave inversion, Right bundle branch block, Ventricular tachycardia, Palpitations, Vertigo, Ventricular extrasystoles, Abnormality of the right ventricle)

      HPOsFreeText: Task force score of 5, Regional right ventricular dyskinesia, PLAX RVOT is 43 mm, 1897 VES / 24 h, LVEF of 64%, LVEDD at 51 mm, IVS at 8 mm

      CaseNotHPOs: HP:0001639, HP:0001711 (Hypertrophic cardiomyopathy, Abnormal morphology of the left ventricle)

      NotHPOsFreeText: Depolarization abnormalities

      CasePreviousTesting: Tested genes include MYH7, MYBPC3, TNNT2, TNNI3, TPM1, ACTC1, TTN, TCAP, ACTN2, LDB3, MYH6, TNNC1, MYPN and NEBL.

      CaseGenotypingMethod: The coding sequences of 15 genes were directly captured and sequenced. Candidate variants were then filtered by pathogenicity and confirmed via sanger sequencing. Family members were tested via Sanger sequencing afterwards.

      CaseAddInfo: Proband is heterozygous for both variants

      Variant: NM_000257.3:c.5116C>G (p.Leu1706Val)

      CAID: CA389036928 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA389036928

      gnomAD: Not in gnomAD

      Multiple Gene Variants

      (1) PKP2 Variant

      Variant: NM_004572.3(PKP2):c.2489+1G>A

      ClinVar: 6757 https://www.ncbi.nlm.nih.gov/clinvar/variation/6757/

      gnomAD: 0.00008012, http://gnomad.broadinstitute.org/variant/12-32949042-C-T

    1. Table III

      Case 94: Italian, 30yo,

      DiseaseAssertion: HCM

      CasePresentingHPOs: HP:0001712 (left ventricular hypertrophy)

      CaseHPOFreeText: LVWT = 24mm, LV ejection fraction = 65%

      CasePreviousTesting: echocardiography, Full testing (MYBPC3, MYH7, TNNT2, TNNI3, TPM1, MYL2, MYL3, ACTC1), additional testing Sanger: (GLA, LAMP2, PRKAG2), additional testing NGS: (TNNC1, MYH6, MYOM1, MYOZ2, ANKRD1, VCL, CALR3, CAV3)

      CaseGenotypingMethod: Genomic DNA extracted from peripheral leukocytes, Sanger sequencing (73 samples), Next-gen sequencing (19 samples)

      Variant: NM_000257.3:c.161G>T

      CAID: CA028998, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA028998

      gnomAD: 0.000003977, https://gnomad.broadinstitute.org/variant/14-23902781-C-A

      MultipleGeneVariants:

      (1) MYBPC3 Variant:

      Variant: NM_000256.3(MYBPC3):c.1174delG (p.Ala392Leufs)

      ClinVar: 568945, https://www.ncbi.nlm.nih.gov/clinvar/variation/568945/

      gnomAD: n/a

      (2) TNNT2 Variant:

      Variant: NM_000364.3(TNNT2):c.853C>T (p.Arg285Cys)

      ClinVar: 12411, https://www.ncbi.nlm.nih.gov/clinvar/variation/12411/

      gnomAD: 0.0003556, https://gnomad.broadinstitute.org/variant/1-201328373-G-A

      (3) MYOM1 Variant:

      Variant: NM_003803.3(MYOM1):c.2087G>A (p.Arg696His)

      ClinVar: 525100, https://www.ncbi.nlm.nih.gov/clinvar/variation/525100/

      gnomAD: 0.0002032, https://gnomad.broadinstitute.org/variant/18-3135667-C-T

    1. BJJ

      CaseBJJ: 16 years diagnosis, Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: No family history of HCM or Sudden Cardiac Death

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: Maximum left ventricular hypertrophy at 22 mm,

      CaseNotHPOs: N/A

      NotHPOsFreeText: Sudden cardiac death events

      CaseAddInfo: Cis/trans status is unknown

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant1: NM_000257.3:c.2389G>A (p.Ala797Thr)

      ClinVar: 42901 https://www.ncbi.nlm.nih.gov/clinvar/variation/42901/

      gnomAD: African 1.230e-4, Overall 2.386e-5 https://gnomad.broadinstitute.org/variant/14-23894525-C-T

      Variant2: NM_000257.3:c.2420G>A (p.Arg807His)

      ClinVar: 391904 https://www.ncbi.nlm.nih.gov/clinvar/variation/391904/

      gnomAD: Latino 5.644e-5, Overall 1.414e-5 https://gnomad.broadinstitute.org/variant/14-23894494-C-T

    2. CaseMYH7-39: Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant: NM_000257.3:c.952A>C (p.Thr318Pro)

      CAID: CA389051682 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000257.3%3Ac.952A%3EC

      gnomAD: Not in gnomAD

    3. CaseMYH7-26: Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant: NM_000257.3:c.2167C>T (p.Arg723Cys)

      ClinVar: 14095 https://www.ncbi.nlm.nih.gov/clinvar/variation/14095/

      gnomAD: South Asian 3.266e-5, Overall 1.194e-5 https://gnomad.broadinstitute.org/variant/14-23895023-G-A

    4. CaseMYH7-3: Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant: NM_000257.3:c.5222_5223del (p.Val1741Glyfs*11)

      CAID: CA913184899 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA913184899

      gnomAD: Not in gnomAD

    5. CaseMYH7-15: Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant: NM_000257.3:c.2738T>C (p.Ile913Thr)

      CAID: CA389047215 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000257.3%3Ac.2738T%3EC

      gnomAD: Not in gnomAD

    6. CaseMYH7-1: Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant: NM_000257.3:c.5452C>T (p.Arg1818Trp)

      ClinVar: 217826 https://www.ncbi.nlm.nih.gov/clinvar/variation/217826/

      gnomAD: Latino 5.782e-5, Overall 7.956e-6 https://gnomad.broadinstitute.org/variant/14-23884311-G-A

    1. Peripheral blood mononuclear cells (PBMCs) were obtained from a 43-year-old male with familial HCM

      Case: Male, 43yo

      DiseaseAssertion: HCM

      FamilyInfo: Variant (p.Val698Ala) segregates with HCM in 5 family members and 2 others are unaffected carriers

      CaseHPOFreeText: left ventricular wall thickness = 28 mm

      CasePreviousTesting: n/a

      CaseGenotypingMethod: n/a

      Variant: NM_000257.3(MYH7):c.2093T>C (p.Val698Ala) heterozygous

      ClinVar: 42878, https://www.ncbi.nlm.nih.gov/clinvar/variation/42878/

      gnomAD: n/a

    1. Case III-2 (Proband)

      Case#: Case III-2, 42 yr, female, early childhood onset

      DiseaseAssertion: DCM

      FamilyInfo: Family D, her father (II-5) had late-onset foot drop and hand weakness, died at age 51 from a myocardial infarction, her son (IV-3) had a severe generalized weakness since childhood, never walked and had prominent neck extensor contractures, died at age 19 years from a presumed cardiopulmonary event, 2 sisters (III-1 and III-3) had early-onset weakness and foot drop, her nephew (IV-1) had severe weakness and was wheelchair dependent, muscle biopsy, diagnosed with an unspecified muscular dystrophy, her niece (IV-2) had severe congenital weakness and died in her teens, all affected family members had contractures of neck extensors, heel cords, knee flexors, and elbow flexors

      CasePresentingHPOs: progressive muscle weakness, lower limb muscle weakness, gait disturbance, slender build, scapular winging, thoracic scoliosis, weakness of facial musculature, generalized limb muscle atrophy, sinus tachycardia (HP:0003323, HP:0007340, HP:0001288, HP:0001533, HP:0003691, HP:0002943, HP:0030319, HP:0009055, HP:0011703)

      CaseHPOFreeText: weakness and gait at age 5, nonambulatory by late-teens, wheelchair dependent, neck muscle atrophy, hypoactive myotatic reflexes

      CaseNotHPOs: respiratory distress, syncope, chest pain, palpitations (HP:0002098, HP:0001279, HP:0100749, HP:0001962)

      CaseNotHPOFreeText: normal sensory

      CasePreviousTesting: Analysis included most of the other congenital myopathy genes and was otherwise negative

      CaseGenotypingMethod: neurological examination, serum creatine kinase, nerve conduction studies, concentric needle electromyography, electrocardiogram, echocardiogram, forced vital capacity, muscle biopsy, immunohistochemical analyses, strength testing (MRC 3/2), arm flexors (MRC 4/4), arm extensors (MRC 3/3), wrist flexors (MRC 3/3), wrist extensors (MRC 1/3), finger flexors (MRC 2/2), finger extensors (MRC 2/2), finger adductors and abductors (MRC 4/4), hip flexors (MRC 2/2), hip abductors and adductors (MRC 3/3), knee flexors (MRC 2/2), knee extensors (MRC 2/2), foot dorsiflexors (MRC 0/0), plantar flexors (MRC 3/3) toe flexors (MRC 2/2), and toe extensors (MRC 1/1), normal 0.82 L (25%) FVC, 25% left ventricular ejection fraction, normal NCSs, increased small polyphasic MUAP, occasional fibrillation potentials, positive sharp waves, and brief myotonic discharges, facioscapulohumeral muscular dystrophy type 1, Emery–Dreifuss muscular dystrophy (EMD, LMNA, and FHL1 gene disorders), and limb-girdle muscular dystrophy type 1C were negative

      Variant: NM_000257.2

      ClinVar: absent

      CAID: absent

      gnomAD: absent

    2. Case III-2 (Proband)

      Case#: Case III-2, female, 64 yr, early childhood onset

      DiseaseAssertion: None

      FamilyInfo: Family C, her mother (II-1) and maternal grandmother (I-1) had late-onset leg weakness (Fig. 1C), her brother (III-4) had severe generalized weakness and was diagnosed with an unspecified muscular dystrophy

      CasePresentingHPOs: Gait disturbance, lower limb muscle weakness, hypertension, osteoarthritis, hyperlipidemia, glaucoma, neck flexor weakness, weakness of facial musculature, weakness of long finger extensor muscles, foot dorsiflexor weakness (HP:0001288, HP:0007340, HP:0000822, HP:0002758, HP:0003077, HP:0000501, HP:0003722, HP:0030319, HP:0009077, HP:0009027)

      CaseHPOFreeText: mild heel cord contractures, mild eye closure weakness, unable to stand on heels, limb weakness

      CaseNotHPOs: Scoliosis, scapular winging, generalized muscle hypertrophy (HP:0002650, HP:0003691, HP:0003720)

      CaseNotHPOFreeText: hand or foot deformities, normal knee bend and stand on tiptoes, normal reflexes and sensory

      CasePreviousTesting: N/A

      CaseGenotypingMethod: neurological examination, serum creatine kinase, nerve conduction studies, concentric needle electromyography, electrocardiogram, echocardiogram, forced vital capacity, muscle biopsy, immunohistochemical analyses, CK 156 unit/L (n < 143), FVC 2.13 L (68%), ECG and echo normal, left ventricular ejection fraction 65%, normal NCS except low-amplitude peroneal and tibial compound muscle action potential, abnormal increase of small polyphasic MUAP in tibialis anterior, no fibrillation potentials, no positive sharp waves, no myotonic discharges

      Variant: NM_182476.3(COQ6):c.115G>A (p.Val39Met) & NM_000257.4(MYH7):c.4844_4846AGA[2] (p.Lys1617del)

      ClinVar: 214236 https://www.ncbi.nlm.nih.gov/clinvar/variation/214236/ & 190401 https://www.ncbi.nlm.nih.gov/clinvar/variation/190401/

      CAID: N/A

      gnomAD: 0.00006720 African https://gnomad.broadinstitute.org/variant/14-74417150-G-A & absent

    1. Supplementary Data, Table 2

      Case: Australian

      DiseaseAssertion: HCM

      CaseHPOFreeText: maximum left ventricular wall thickness of ≥15 mm

      CasePreviousTesting: electrocardiography, echocardiography, Full testing (MYBPC3, MYH7, TNNT2, TNNI3, TPM1, MYL2, MYL3, ACTC1)

      CaseGenotypingMethod: DNA isolated from peripheral blood or buccal swabs, PCR, Sanger sequencing, segregation analysis, haplotype analysis of MYBPC3 and MYH7

      Variant: NM_000257.3(MYH7):c.4066G>A (p.Glu1356Lys)

      ClinVar: 164294, https://www.ncbi.nlm.nih.gov/clinvar/variation/164294/

      gnomAD: n/a

    2. Supplementary Data, Table 2

      Case: Australian

      DiseaseAssertion: HCM

      CaseHPOFreeText: maximum left ventricular wall thickness of ≥15 mm

      CasePreviousTesting: electrocardiography, echocardiography, Full testing (MYBPC3, MYH7, TNNT2, TNNI3, TPM1, MYL2, MYL3, ACTC1)

      CaseGenotypingMethod: DNA isolated from peripheral blood or buccal swabs, PCR, Sanger sequencing, segregation analysis, haplotype analysis of MYBPC3 and MYH7

      Variant: NM_000257.3(MYH7):c.1051A>G (p.Lys351Glu)

      ClinVar: 181335, https://www.ncbi.nlm.nih.gov/clinvar/variation/181335/

      gnomAD: n/a

    1. Table 1 and 4

      Case 64: Male, 42yo

      DiseaseAssertion: HCM

      FamilyInfo: negative family history

      CaseHPOFreeText: interventricular septum thickness = 18.1mm, left ventricular end diastolic diameter = 51.7mm, left ventricular end systolic diameter = 34.4mm, left ventricular posterior wall thickness = 9.8mm, left atrium = 44mm, left ventricular ejection fraction = 61%

      CasePreviousTesting: 12-lead ECG, echocardiography, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing (LMNA, PRKAG2, SCN5A, MYH6)

      CaseGenotypingMethod: genomic DNA collected from peripheral whole blood samples, PCR, high-throughput sequencing using PGM Sequencing 400 kit, variants verified via Sanger Sequencing

      Variant: NM_000257.3(MYH7):c.1987C>T (p.Arg663Cys)

      ClinVar: 42874, https://www.ncbi.nlm.nih.gov/clinvar/variation/42874/

      gnomAD: n/a

    1. Pedigree 4

      Case: Pedigree 4 proband, congenital (abnormalities noticed at 24wks gestation), Yemenite Jewish

      CasePresentingHPOs: HP:0012817, HP:0010316 (noncompaction cardiomyopathy, Ebstein anomaly)

      HPOsFreeText: clinical severity: moderate to asymptomatic

      CaseNotHPOs:

      NotHPOsFreeText: skeletal involvement

      CasePreviousTesting: none

      CaseGenotypingMethod: MYH7 sequencing

      Variant: NM_000257.4:c.1859T>C (p.Leu620Pro)

      CAID: CA389049669, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA389049669

      gnomAD: n/a

      FamilyInfo: father, the paternal grandmother, and paternal uncle had a known history of Ebstein anomaly and NCCM, proband's 2 sisters are healthy with no evidence of cardiomyopathy, 7 other family members diagnosed with Ebstein anomaly and NCCM, but most were asymptomatic, variant segregated with all affected members in heterozygous state, no unaffected members were genotype positive

    2. Pedigree 3

      Case: Pedigree 3 proband, female, 3mo at diagnosis, North African and Jewish

      CasePresentingHPOs: HP:0001644 (dilated cardiomyopathy)

      HPOsFreeText: clinical severity: severe (fatal)

      CaseNotHPOs:

      NotHPOsFreeText: skeletal involvement

      CasePreviousTesting: exact genes sequenced not specified

      CaseGenotypingMethod: DCM CardioChip, included 19 genes known to cause DCM

      Variant 1: NM_000257.3(MYH7):c.427C>T (p.Arg143Trp)

      ClinVar: 164401, https://www.ncbi.nlm.nih.gov/clinvar/variation/164401/

      gnomAD: 0.00002784, https://gnomad.broadinstitute.org/variant/14-23901923-G-A

      Variant 2: NM_000257.4(MYH7):c.4588C>T (p.Arg1530Ter)

      ClinVar: 43029, https://www.ncbi.nlm.nih.gov/clinvar/variation/43029/

      gnomAD: 0.00001591, https://gnomad.broadinstitute.org/variant/14-23886133-G-A

      FamilyInfo: mother is of North African and Iraqi‐Jewish descent, while the father is of North African and Balkan Jewish descent, probands brother died at 3.5mo and also carried both variants, maternal cousin died of RCM in early childhood, maternal aunt carried p.R143W

    1. Case12: Female, 60 years diagnosis, China, Asian

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: One sibling and one child died of SCD in their 30s, with child having confirmed HCM

      CasePresentingHPOs: HP:0001639, HP:0030148 (Hypertrophic cardiomyopathy, Heart murmur)

      HPOsFreeText: Mixed features of apical and classic HCM

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: Probands were only genotyped for MYH7 and MYBPC3 in that order, stopping once a positive finding was detected.

      CaseGenotypingMethod: Genomic DNA was extracted from peripheral blood. Each gene's coding exons and flanking introns were subject to PCR amplification and sequencing. From there, any variants found were filtered for pathogenicity and low frequencies.

      Variant: NM_000257.3:c.1273G>A (p.Gly425Arg)

      ClinVar: 42834 https://www.ncbi.nlm.nih.gov/clinvar/variation/42834/

      gnomAD: Not in gnomAD

    2. Case15: Female, 48 years diagnosis, China, Asian

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: One parent died of cardiomyopathy/sudden death, one offspring had a heart murmur and found to have HCM

      CasePresentingHPOs: HP:0001639, HP:0001279, HP:0005162, HP:0003546 (Hypertrophic cardiomyopathy, Syncope, Left ventricular failure, Poor exercise tolerance)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: Heart transplantation done

      CasePreviousTesting: Probands were only genotyped for MYH7 and MYBPC3 in that order, stopping once a positive finding was detected.

      CaseGenotypingMethod: Genomic DNA was extracted from peripheral blood. Each gene's coding exons and flanking introns were subject to PCR amplification and sequencing. From there, any variants found were filtered for pathogenicity and low frequencies.

      Variant: NM_000257.3:c.2155C>T (p.Arg719Trp)

      ClinVar: 14104 https://www.ncbi.nlm.nih.gov/clinvar/variation/14104/

      gnomAD: European (Non-Finnish) 6.481e-5, Overall 3.185e-5 https://gnomad.broadinstitute.org/variant/14-23895180-G-A

    1. Supplementary Material 4

      Case M-10: Japanese

      DiseaseAssertion: idiopathic cardiomyopathy (HCM and DCM)

      CasePreviousTesting: Clinical evaluation, chest radiography, electrocardiography, echocardiography, cardiac catheterization, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1)

      CaseGenotypingMethod: 8 sarcomeric genes amplified from genomic DNA via PCR then screened using bidirectional direct sequencing

      Variant: NM_000257.3(MYH7):c.1987C>T (p.Arg663Cys)

      ClinVar: 42874, https://www.ncbi.nlm.nih.gov/clinvar/variation/42874/

      gnomAD: n/a

    2. Supplementary Material 4

      Case M-6: Japanese

      DiseaseAssertion: idiopathic cardiomyopathy (HCM and DCM)

      CasePreviousTesting: Clinical evaluation, chest radiography, electrocardiography, echocardiography, cardiac catheterization, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1)

      CaseGenotypingMethod: 8 sarcomeric genes amplified from genomic DNA via PCR then screened using bidirectional direct sequencing

      Variant 2: NM_000257.3(MYH7):c.1357C>T (p.Arg453Cys)

      ClinVar: 14089, https://www.ncbi.nlm.nih.gov/clinvar/variation/14089/

      gnomAD: n/a

    3. Supplementary Material 4

      Case M-23: Japanese

      DiseaseAssertion: idiopathic cardiomyopathy (HCM and DCM)

      CasePreviousTesting: Clinical evaluation, chest radiography, electrocardiography, echocardiography, cardiac catheterization, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1)

      CaseGenotypingMethod: 8 sarcomeric genes amplified from genomic DNA via PCR then screened using bidirectional direct sequencing

      Variant: NM_000257.3(MYH7):c.2546T>C (p.Met849Thr)

      ClinVar: 42914, https://www.ncbi.nlm.nih.gov/clinvar/variation/42914/

      gnomAD: n/a

    4. Supplementary Material 4

      Case M-30: Japanese

      DiseaseAssertion: idiopathic cardiomyopathy (HCM and DCM)

      CasePreviousTesting: Clinical evaluation, chest radiography, electrocardiography, echocardiography, cardiac catheterization, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1)

      CaseGenotypingMethod: 8 sarcomeric genes amplified from genomic DNA via PCR then screened using bidirectional direct sequencing

      Variant: NM_000257.3(MYH7):c.2803G>A (p.Glu935Lys)

      ClinVar: 14106, https://www.ncbi.nlm.nih.gov/clinvar/variation/14106/

      gnomAD: n/a

    5. Supplementary Material 4

      Case M-9: Japanese

      DiseaseAssertion: idiopathic cardiomyopathy (HCM and DCM)

      CasePreviousTesting: Clinical evaluation, chest radiography, electrocardiography, echocardiography, cardiac catheterization, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1)

      CaseGenotypingMethod: 8 sarcomeric genes amplified from genomic DNA via PCR then screened using bidirectional direct sequencing

      Variant: NM_000257.3(MYH7):c.1987C>T (p.Arg663Cys)

      ClinVar: 42874, https://www.ncbi.nlm.nih.gov/clinvar/variation/42874/

      gnomAD: n/a

    6. Supplementary Material 4

      Case M-26: Japanese

      DiseaseAssertion: idiopathic cardiomyopathy (HCM and DCM)

      CasePreviousTesting: Clinical evaluation, chest radiography, electrocardiography, echocardiography, cardiac catheterization, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1)

      CaseGenotypingMethod: 8 sarcomeric genes amplified from genomic DNA via PCR then screened using bidirectional direct sequencing

      Variant: NM_000257.3(MYH7):c.2609G>A (p.Arg870His)

      ClinVar: 14120, https://www.ncbi.nlm.nih.gov/clinvar/variation/14120/

      gnomAD: 0.000007072, https://gnomad.broadinstitute.org/variant/14-23894048-C-T

    1. HCM443

      Case#: HCM443, female, 28 years, not a smoker

      DiseaseAssertion: HCM

      FamilyInfo: None

      CasePresentingHPOs: 46mm LAD, 17mm LVST, 44mm LVEDD, 69% LVEF, 18mm Maxi LVWT, 68mmHg Maxi LVOTG, 103385170 raw RNA-seq reads, 96969874 HQ reads (93.79%), 96.18% mapping rate, 707524 total variant, 33016 exonic variant

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      CaseGenotypingMethod: RNA-seq, read mapping, variant calling, identify functional variants, differential expression analysis, miRWalk miRNA target prediction, LncRNA annotation, Co-expression network analysis, PPI network analysis, gene over-representation analysis,

      Variant: NM_000257.4(MYH7):c.2221G>T (p.Gly741Trp)

      ClinVar: 177665 https://www.ncbi.nlm.nih.gov/clinvar/variation/177665/

      CAID: N/A

      gnomAD: absent

    2. HCM431

      Case#: HCM431, male, 24 years, not a smoker

      DiseaseAssertion: HCM

      FamilyInfo: None

      CasePresentingHPOs: 57mm LAD, 18mm LVST, 49mm LVEDD, 80% LVEF, 21mm Maxi LVWT, 80mmHg Maxi LVOTG, 95467544 raw RNA-seq reads, 91611504 HQ reads (95.96%), 96.60% mapping rate, 701266 total variant, 33263 exonic variant

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      CaseGenotypingMethod: RNA-seq, read mapping, variant calling, identify functional variants, differential expression analysis, miRWalk miRNA target prediction, LncRNA annotation, Co-expression network analysis, PPI network analysis, gene over-representation analysis,

      Variant: NM_000257.4(MYH7):c.4066G>A (p.Glu1356Lys)

      ClinVar: 164294 https://www.ncbi.nlm.nih.gov/clinvar/variation/164294/

      CAID: N/A

      gnomAD: absent

    3. HCM483

      Case#: HCM483, male, 37 years, smoker

      DiseaseAssertion: HCM

      FamilyInfo: None

      CasePresentingHPOs: 57mm LAD, 23mm LVST, 40mm LVEDD, 72% LVEF, 26mm Maxi LVWT, 70mmHg Maxi LVOTG, 132375212 raw RNA-seq reads, 125845538 HQ reads (95.07%), 96.52% mapping rate, 838862 total variant, 35806 exonic variant

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      CaseGenotypingMethod: RNA-seq, read mapping, variant calling, identify functional variants, differential expression analysis, miRWalk miRNA target prediction, LncRNA annotation, Co-expression network analysis, PPI network analysis, gene over-representation analysis,

      Variant: NM_000257.4(MYH7):c.1816G>A (p.Val606Met)

      ClinVar: 14091 https://www.ncbi.nlm.nih.gov/clinvar/variation/14091/

      CAID: N/A

      gnomAD: 0.00001548 European (non-finnish) https://gnomad.broadinstitute.org/variant/14-23896866-C-T

    1. eighth case

      Case#: 8th case, male, 49 years

      DiseaseAssertion: SHCM

      FamilyInfo: No

      CasePresentingHPOs: Mycardial fibrosis (HP:0001685)

      CaseHPOFreeText: 630 g heart, IVST to LVWT ratio 1.38, IVST 2.2 cm, LVWT 1.6 cm, hypertrophy of myocardial fibers, stenosis in lumens,

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: no pathological changes found in major organs besides heart

      CasePreviousTesting: N/A

      CaseGenotypingMethod: physical examination, ECG, 2D and Doppler echocardiography, histological examinations, genomic DNA extraction, DNA cloning, sequence analysis

      Variant: NC_000014.9:g.23429026T>G (Thr446Pro)

      ClinVar: absent

      CAID: CA257823360

      gnomAD: absent

    1. Table 5

      Case EO23: Italian

      DiseaseAssertion: HCM (early-onset)

      CasePreviousTesting: echocardiography, Full testing (MYBPC3, MYH7, TNNT2, TNNI3, TPM1, MYL2, MYL3, ACTC1), additional testing: (GLA, LAMP2, PRKAG2, TNNC1, MYH6, CSPR3, PLN, TCAP, CAV3), electrocardiography

      CaseGenotypingMethod: Genomic DNA extracted from periphera whole blood, emulsion PCR, 17 HCM genes sequenced using Personal Genome Machine (PGM) IonTorrent sequencer, variants confirmed via Sanger sequencing

      Variant1: NM_000257.3:c.3973G>A

      CAID: CA389041353, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA389041353

      gnomAD: n/a

      Variant2: NM_000257.3(MYH7):c.2804A>T (p.Glu935Val)

      ClinVar: 181207, https://www.ncbi.nlm.nih.gov/clinvar/variation/181207/

      gnomAD: n/a

    2. Table 5

      Case LO13: Italian

      DiseaseAssertion: HCM (late-onset)

      FamilyInfo: positive family history

      CasePreviousTesting: echocardiography, Full testing (MYBPC3, MYH7, TNNT2, TNNI3, TPM1, MYL2, MYL3, ACTC1), additional testing: (GLA, LAMP2, PRKAG2, TNNC1, MYH6, CSPR3, PLN, TCAP, CAV3), electrocardiography

      CaseGenotypingMethod: Genomic DNA extracted from periphera whole blood, emulsion PCR, 17 HCM genes sequenced using Personal Genome Machine (PGM) IonTorrent sequencer, variants confirmed via Sanger sequencing

      Variant: NM_000257.3(MYH7):c.1816G>A (p.Val606Met)

      ClinVar: 14091, https://www.ncbi.nlm.nih.gov/clinvar/variation/14091/

      gnomAD: 0.000007070, https://gnomad.broadinstitute.org/variant/14-23896866-C-T

    1. 16

      Case: Patient 16, female, 39yo, symptom onset in adulthood

      CasePresentingHPOs: HP:0030237, HP:0003327, HP:0003701, HP:0002460, HP:0003458 (hand muscle weakness, axial muscle weakness, proximal muscle weakness, distal muscle weakness, EMG: myopathic abnormalities)

      HPOsFreeText: normal CK values

      CaseNotHPOs: HP:0002650 (scoliosis)

      NotHPOsFreeText: no respiratory or cardiac involvement

      FamilyInfo: no family history

      DiseaseEntity: no assertion

      InheritancePattern: no assertion

      CasePreviousTesting: see below

      CaseGenotypingMethod: 9 cases underwent targeted Sanger sequencing of MYH7, 12 cases underwent Motorplex analysis (NGS of 93 myopathy-related genes - PMID:25214167), all MYH7 variants confirmed via Sanger sequencing, segregation analysis performed on available family members, which cases received which sequencing technique is not specified

      Variant: NM_000257.3:c.1780C>A

      CAID: CA389049833, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA389049833

      gnomAD: absent

    2. 7

      Case: Patient 7, male, 8yo, congenital onset of symptoms

      CasePresentingHPOs: HP:0003327, HP:0002650, HP:0030682, HP:0003458 (axial muscle weakness, scoliosis, left ventricular noncompaction, EMG: myopathic abnormalities)

      HPOsFreeText: minicores present on muscle biopsy

      FamilyInfo: no family history

      DiseaseEntity: no assertion

      InheritancePattern: no assertion

      CasePreviousTesting: see below

      CaseGenotypingMethod: 9 cases underwent targeted Sanger sequencing of MYH7, 12 cases underwent Motorplex analysis (NGS of 93 myopathy-related genes - PMID:25214167), all MYH7 variants confirmed via Sanger sequencing, segregation analysis performed on available family members, which cases received which sequencing technique is not specified

      Variant: NM_000257.3:c.5655+1G>A

      CAID: CA389034770, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA389034770

      gnomAD: absent

    1. CaseMYH7-5: Japan, Asian

      CasePresentingHPOs: HP:0001639, HP:0006685 (Hypertrophic cardiomyopathy, Endomyocardial fibrosis)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo:


      CaseGenotypingMethod: Genomic DNA was extracted from whole blood from each proband. They each had 95 genes associated with DCM, HCM, and other inherited cardiovascular diseases sequenced with a panel, including both the exons and spicing regions. Variants were then filtered for rarity and pathogenicity.


      Variant: NM_000257.3:c.2155C>T (p.Arg719Trp)

      ClinVar: 14104 https://www.ncbi.nlm.nih.gov/clinvar/variation/14104/

      gnomAD: European (Non-Finnish) 6.481e-5, Overall 3.185e-5 https://gnomad.broadinstitute.org/variant/14-23895180-G-A

    2. CaseMYH7-1: Japan, Asian

      CasePresentingHPOs: HP:0001639, HP:0006685 (Hypertrophic cardiomyopathy, Endomyocardial fibrosis)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo:


      CaseGenotypingMethod: Genomic DNA was extracted from whole blood from each proband. They each had 95 genes associated with DCM, HCM, and other inherited cardiovascular diseases sequenced with a panel, including both the exons and spicing regions. Variants were then filtered for rarity and pathogenicity.


      Variant: NM_000257.3:c.2803G>A (p.Glu935Lys)

      ClinVar: 14106 https://www.ncbi.nlm.nih.gov/clinvar/variation/14106/

      gnomAD: Not in gnomAD

    1. Case 2

      Case2: female, 16 years old

      DiseaseAssertion: Myopathy

      FamilyInfo:

      CasePresentingHPOs: HP:0040083, HP:0002650, HP:0003722, HP:0001371, HP:0009027, HP:0012515

      "Toe walking, Scoliosis, Neck flexor weakness, Flexion contractures, Foot dorsiflexor weakness, Hip flexor weakness"

      CaseHPOFreeText: Presented with toe-walking at age 5 years and required bilateral tendo-Achilles releases at ages 7 and 13 years. A progressive scoliosis required surgical stabilization at age 12 years. At age 13 years neck movements were markedly restricted in all directions except extension, and there were mild flexion contractures at the hips, knees and ankles. There was marked neck flexion weakness, moderate weakness of hip extension and ankle dorsiflexion, and mild weakness of shoulder abduction, hip flexion and knee flexion/extension. While walking her upper body was angled forward, there was external rotation of the feet and mild foot-drop. The axial involvement in this case largely spares the lumbar musculature and is restricted to the upper thoracic and neck regions.

      CaseNotHPOs:

      CaseNotHPOFreeText:

      CasePreviousTesting: Serum creatine kinase was 308 iu/l (24–215). There was moderate restrictive lung disease (as determined by formal pulmonary function testing) at age 12 years (FVC 55% of predicted). Electromyography, sural nerve biopsy and cardiac investigations (EKG and echocardiogram) were normal. A quadriceps muscle biopsy taken at age 13 years demonstrated congenital fiber type disproportion. There was type 1 fiber predominance (82%), marked type 1 hypotrophy and type 2 fiber hypertrophy. Muscle MRI scan at age 12 years showed selective fatty infiltration of spinalis muscles in the upper thoracic and cervical regions. Unreported heterozygous variants in RYR1 (p.Asn4200Ser), COL6A3 (p.Ser2829Pro) and TTN (p.Gly4604Glu) were detected, but were all present in a healthy parent. In addition, Sanger sequencing was normal for ACTA1, SEPN1, LMNA, TPM3, TPM2, TNNT1 and MYOZ2.

      GenotypingMethod: A heterozygous MYH7 p.Leu1597Arg (c.4790T>G) missense change was found by whole exome sequencing studies, and confirmed by Sanger sequencing. This change was absent in parental DNA samples.

      Variant: NM_000257.4:c.4790T>G (MYH7)

      ClinVar: not found

      CAID: CA389037627

      gnomAD: not found

    1. Family A, the proband

      Case: Family A proband, female, Saudi Arabia, 10mo at presentation

      CasePresentingHPOs: HP:0001635, HP:0001644, HP:0005185, HP:0012664, HP:0006677, HP:0011713 (heart failure, dilated cardiomyopathy, global systolic dysfunction, reduced ejection fraction, prolonged QRS complex, left bundle branch block)

      HPOsFreeText: decompensated heart failure, diastolic dysfunction, left ventricle end-diastolic diameter = 120cm, left ventricular end systolic diameter = 0.4cm, left ventricular ejection fraction = 25%, left ventricular posterior wall thickness = 0.4cm, heat rate = 140bpm

      CaseNotHPOs: HP:0011703 (sinus tachycardia)

      FamilyInfo: consanguineous, family history of heart disease, pedigree in Fig. 1

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, TPM1, ACTC1; 181 genes, Supplementary Data Table S1

      CaseGenotypingMethod: genomic DNA extracted from peripheral blood, NGS (181 genes, Supplementary Data Table S1), variants confirmed via Sanger sequencing, parents tested

      InheritancePattern: autosomal dominant

      Variant: NM_000257.3(MYH7):c.2770G>A (p.Glu924Lys)

      ClinVar: 14092, https://www.ncbi.nlm.nih.gov/clinvar/variation/14092/

      gnomAD: n/a

      MultipleGeneVariants:

      (1) LAMA4 Variant

      Variant: NM_001105206.2:c.3925G>A

      CAID: CA365374078, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA365374078

      gnomAD: n/a

    1. Mutation Spectrum in a Large Cohort of Unrelated Chinese Patients With Hypertrophic Cardiomyopathy

      PMID: 23711808

      Gene: MYH7

      HGNC: 7577

      Direct gene sequencing of β-myosin heavy chain (MYH7), myosin binding protein-C (MYBPC3), and cardiac troponin T (TNNT2) was performed in 136 unrelated Chinese HC patients. Clinical evaluations were conducted. In total, 32 mutations were identified in 36 patients (27%), including 10 novel ones. Distribution of mutations was 56% (MYBPC3), 31% (MYH7), and 13% (TNNT2), respectively. Double mutations were identified in 3% patients.

    1. Supplemental data table e-1

      Case: MYH7 Case 1

      InheritancePattern: autosomal recessive

      DiseaseEntity: n/a

      PreviouslyPublished: PMID: 29300372

      PreviousTesting: Not specified

      CaseGenotypingMethod: paper notes single gene, NGS, and WES were used, but does not specify which method was used for each individual family

      Variant: NM_000257.4(MYH7):c.1358G>A (p.Arg453His)

      ClinVar: 42838, https://www.ncbi.nlm.nih.gov/clinvar/variation/42838/

      gnomAD: n/a

    2. Supplemental data table e-1

      Case: MYH7 Case 2

      InheritancePattern: autosomal recessive

      DiseaseEntity: n/a

      PreviouslyPublished: PMID: 27282841

      PreviousTesting: Not specified

      CaseGenotypingMethod: paper notes single gene, NGS, and WES were used, but does not specify which method was used for each individual family

      Variant: NM_000257.4(MYH7):c.5459G>A (p.Arg1820Gln)

      ClinVar: 419278, https://www.ncbi.nlm.nih.gov/clinvar/variation/419278/

      gnomAD: 0.00001989, https://gnomad.broadinstitute.org/variant/14-23884304-C-T

    1. Country: Portugal

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      GenotypingMethod: Genetic testing was performed at the discretion of participating centers and laboratories. All variants were classified by pathogenicity based on ClinVar interpretations and populations frequency.

      PreviousTesting: All nine sarcomeric genes (MYH7, MYBPC3, TNNT2, TNNI3, MYL2, MYL3, ACTC1, TPM1, CSRP3) were compared with others likely being done depending on the submitting center/lab.

      VariantAddInfo: 7 individuals inc. carriers reported

      Variant: NM_000257.4(MYH7):c.2539_2541del (p.Lys847del)

      ClinVar: 42913 https://www.ncbi.nlm.nih.gov/clinvar/variation/42913/

      gnomAD: Not in gnomAD

    1. 16

      Case#: 16, female, diagnosed as fetus,

      DiseaseAssertion: LVNC

      FamilyInfo: yes

      CasePresentingHPOs: cyanosis, Ebstein anomaly of the tricuspid valve, Ventricular septal defect, coarctation of aorta, congestive heart failure (HP:0000961, HP:0010316, HP:0001629, HP:0001680, HP:0001635)

      CaseHPOFreeText: -5.47 Fathmm, 0 sift, 0.001 polyphen2, 0 GVGD, mutation taster 1, -3.64 provean, -5.15 CADD,

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: no extracardiac abnormalities

      CasePreviousTesting: N/A

      CaseGenotypingMethod: physical examination, ECG, variant screening and classification, genic collapsing test, group statistical analysis

      Variant: absent

      ClinVar: absent

      CAID: CA389051391 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA389051391

      gnomAD: absent

    1. 4

      Case4: Male, 26 years report, Netherlands

      CasePresentingHPOs: HP:0011663, HP:0011675, HP:0001279, HP:0005135, HP:0001707, HP:0004308, HP:0001711 (Right ventricular cardiomyopathy, Arrhythmia, Syncope, Abnormal T-wave, Abnormality of the right ventricle, Ventricular arrhythmia, Abnormality of the left ventricle)

      HPOsFreeText: Positive EPS inducibility

      CaseNotHPOs: HP:0001639, HP:0001635 (Hypertrophic cardiomyopathy, Congestive heart failure)

      NotHPOsFreeText: ECG Depolarization abnormality, Cardiac transplant

      CaseAddInfo:


      CasePreviousTesting: No variants were in any of DSP, PKP2, DSG2, DSC2, and JUP. Patients were tested for variants in ACTC1, MYBPC3, MYH7, MYL2, MYL3, TNNC1, TNNI3, TNNT2, and TPM1.

      CaseGenotypingMethod: 92 patients underwent panel sequencing of the specific genes listed above, and 45 were subject to Whole Exome Sequencing to locate variants. Afterwards, all variants were verified by PCR amplification and Sanger sequencing and filtered for pathogenicity.


      Variant: NM_000257.3:c.2167C>T (p.Arg723Cys)

      ClinVar: 14095 https://www.ncbi.nlm.nih.gov/clinvar/variation/14095/

      gnomAD: South Asian 3.266e-5, Overall 1.194e-5 https://gnomad.broadinstitute.org/variant/14-23895023-G-A

    1. CaseA: Female, 49 yrs report

      DiseaseEntity: Hypertrophic Cardiomyopathy (AD)

      FamilyInfo: Has a monozygotic twin sister w/ same genotype and similar phenotype who lived far apart and had different living environments / life habits, Other family members were diagnosed with HCM afterwards and were genotype positive, See Figure 3 for pedigree

      CasePresentingHPOs: HP:0001962, HP:0002875, HP:0001639, HP:0005110, HP:0031185, HP:0011713, HP:0001670, HP:0031295, HP:0030718, HP:0006683, HP:0001712 (Palpitations, Exertional dyspnea, Hypertrophic cardiomyopathy, Atrial fibrillation, Increased NT-proBNP level, Left bundle branch block, Asymmetric septal hypertrophy, Left atrial enlargement, Right atrial enlargement, Abnormal ventricular filling, Left ventricular hypertrophy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0031480 (Abnormal mitral valve leaflet morphology)

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: Elevated cardiac troponin T (cTnT) (19 ng/L; reference 0-14), Elevated N-terminal pro-brain natriuretic peptide (NT-proBNP) (10,214 pg/mL; reference 0-88 pg/mL), Electrocardiogram (ECG) and multi-modality imaging

      CaseGenotypingMethod: Whole exome sequencing was performed in the twins using Illumina Hiseq 2500. Low quality variations were filtered and analysed to find potentially pathogenic mutations. The findings were then confirmed using Sanger sequencing.

      Variant: NM_000257.4(MYH7):c.2302G>A (p.Gly768Arg)

      ClinVar: 164337 https://www.ncbi.nlm.nih.gov/clinvar/variation/164337/

      gnomAD: Not in gnomAD

    1. 18-year-old man was referred for evaluation after a markedly abnormal ECG

      Case1: 18 year old male

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: parents and 2 siblings all phenotype negative for HCM, tested negative for the mutation

      CasePresentingHPOs: HP:0001639, HP:0031992, HP:0031972, HP:0004755, HP:0004756

      "Hypertrophic cardiomyopathy, Apical hypertrophic cardiomyopathy, presyncope, Supraventricular tachycardia, Ventricular tachycardia"

      CasePreviousTesting: Authors simply state "on genetic testing"

      Variant: NM_000257.4:c.1588A>G

      ClinVar: 520309

      CAID: CA028909

      gnomAD: https://gnomad.broadinstitute.org/variant/14-23897094-T-C?dataset=gnomad_r2_1

      Total Allele Frequency 0.000003980 South Asian 0.00003266

    1. healthy 16-year-old white young woman

      Case1: 16 yo Caucasian female

      DiseaseAssertion: MYH7 mediated cardiomyopathy

      FamilyInfo: 6 additional family members were found to be at risk for HCM and were advised of recommendations for both

      CasePresentingHPOs: HP:0001640, HP:0031319, HP:0031318, HP:0001655, HP:0002181

      "Cardiomegaly, Cardiomyocyte hypertrophy, Myofiber disarray, Patent foramen ovale, Cerebral edema"

      CaseHPOFreeText: moderately enlarged heart (352 g; expected range, 119–290 g), myocardium exhibited marked myocyte hypertrophy, myocyte disarray, and mild interstitial fibrosis, most notably in the anterolateral left ventricle, fatty streaks present in the thoracic aorta

      CaseNotHPOs: n/a

      CaseNotHPOFreeText: overt septal hypertrophy

      CasePreviousTesting: n/a

      GenotypingMethod: Whole Exome Next-Generation DNA Sequencing, gene-specific surveillance of all known LQTS, CPVT, BrS, HCM, DCM, and ACM genes (90 total; Table 1 and Figure 1), pathogenic mutations were confirmed in the SUD case's genomic DNA by using standard polymerase chain reaction and Sanger DNA sequencing methods

      Variant: NM_000257.4:c.746G>A

      ClinVar: 14088

      CAID: CA016781

      gnomAD: not found

    1. The proband (III1)

      CaseIII-1: Male, China, Asian, 51 years report

      CasePresentingHPOs: HP:0001962, HP:0100749, HP:0002094, HP:0500020, HP:0031185, HP:0004755, HP:0031295, HP:0011103 (Heart palpitations, Chest pain, Dyspnea, Abnormal cardiac biomarker test, Increased NT-proBNP level, Supraventricular tachycardia, Left atrial enlargement, Abnormality of the left ventricular outflow tract)

      HPOsFreeText: Experienced palpitations for 9 years, Chest pain and mild dyspnea for 2 years, Slightly elevated cardiac troponin T level of 21.8 ng/L (normal 0 to 14 ng/L), Significantly elevated N-terminal pro-brain natriuretic peptide level of 537 pg./mL (normal 0 to 125 pg/mL), ECG showed non-specific ST_T change, Preserved biventricular systolic function, Severe LV outflow tract obstruction (peak aortic outflow velocity = 4.8 m/s, peak gradient = 92 mmHg), Proband had a sigmoid septum with LV outflow tract obstruction and LV mass index to body surface area (BSA) of 87.2 g/m2

      CaseNotHPOs: HP:0001677 (Coronary artery disease)

      NotHPOsFreeText: N/A

      CaseAddInfo:


      CaseGenotypingMethod: Genomic DNA was acquired from the proband and all surviving members of his extended family. These were all tested by a 117 gene screening panel that were connected to Cardiomyopathy. The results were confirmed by Sanger sequencing and the variants found were filtered for pathogenicity.


      Variant: NM_000257.3:c.4130C>T (p.Thr1377Met)

      ClinVar: 42992 https://www.ncbi.nlm.nih.gov/clinvar/variation/42992/

      gnomAD: European (Non-Finnish) 8.791e-6, Overall 3.977e-6 https://gnomad.broadinstitute.org/variant/14-23887458-G-A


      Segregation

      Affected: 9

      Unaffected: 17

      Segregations: 23

      PublishedLOD: N/A

      eLOD: 6.92

      AddSegInfo: 6 individuals died before this investigation so clinical data and phenotypes could not be collected, 10 individuals were genotype positive but phenotype negative

    1. Digenic mutational inheritance of the integrin alpha 7 and the myosin heavy chain 7B genes causes congenital myopathy with left ventricular non-compact cardiomyopathy

      PMID: 23800289

      Gene: MYH7

      HGNC: 7577

      "This is the first indication that a mutation in the MYH7B gene causes LVNC cardiomyopathy. We demonstrated that the arginine at position 890 of the MYH7B gene is highly conserved in all species; this region is also conserved in the MYH7 gene, which, when mutated, causes LVNC. These data further support the concept that sarcomere genes are associated with LVNC."

    1. CaseIII-6: Female, 32 years report, 17 years diagnosis, China, Asian

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: Proband's son had the same variant; the father had echocardiograph results but was asymptomatic

      CasePresentingHPOs: HP:0001639, HP:0002094, HP:0100749, HP:0001962, HP:0001279, HP:0030879 (Hypertrophic cardiomyopathy, Dyspnea, Chest pain, Palpitations, Syncope, Interlobular septal thickening on pulmonary HRCT)

      HPOsFreeText: Septum thickness 25 mm, Left ventricle at 44 mm, Left atrium at 40 mm, Ejection fraction at 54%

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: Mutation is classified as de novo

      CasePreviousTesting: See list of 26 genes under Target sequence capture sequencing

      CaseGenotypingMethod: Genomic DNA was extracted from the proband and other family members. Afterwards, it was subject to PCR amplification and sequencing. Any variants found were confirmed with Sanger sequencing before being filtered for pathogenicity.

      Variant: NM_000257.3:c.2146G>A (p.Gly716Arg)

      ClinVar: 14105 https://www.ncbi.nlm.nih.gov/clinvar/variation/14105/

      gnomAD: Not in gnomAD

    1. Case309: Female, 0.01 years onset, Japan, Asian

      DiseaseAssertion: Left ventricular noncompaction

      CasePresentingHPOs: HP:0030682, HP:0025169 (Left ventricular noncompaction, Left ventricular systolic dysfunction)

      HPOsFreeText: Left Ventricular Ejection Fraction at 39%, LVDD-Z score at 1.08

      CaseNotHPOs: HP:0011675 (Arrhythmia)

      NotHPOsFreeText: Congenital heart disease with significant hemodynamic changes

      CaseAddInfo: Father and brother also have LVNC


      CasePreviousTesting: Genes tested include the 8 sarcomere genes as well as 65 more listed in Table S1.

      CaseGenotypingMethod: Genomic DNA was extracted from whole blood from each of the probands. Next Generation Sequencing of 73 genes related to cardiac function was performed, incorporating PCR amplification, and any variants found were subjected to filtering for frequency and pathogenicity. Any variants suggested to be pathogenic were confirmed by Sanger sequencing afterwards.


      Variant: NM_000257.3:c.1085T>G (p.Met362Arg)

      CAID: CA389051391 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000257.3:c.1085T%3EG

      gnomAD: Not in gnomAD

    2. Case280: Male, Birth onset, Japan, Asian

      DiseaseAssertion: Left ventricular noncompaction

      CasePresentingHPOs: HP:0030682, HP:0025169, HP:0001635 (Left ventricular noncompaction, Left ventricular systolic dysfunction, Heart failure)

      HPOsFreeText: Left Ventricular Ejection Fraction at 40%, LVDD-Z score at 2.16

      CaseNotHPOs: HP:0011675 (Arrhythmia)

      NotHPOsFreeText: Congenital heart disease with significant hemodynamic changes

      CaseAddInfo: No family history, Died since publication


      CasePreviousTesting: Genes tested include the 8 sarcomere genes as well as 65 more listed in Table S1.

      CaseGenotypingMethod: Genomic DNA was extracted from whole blood from each of the probands. Next Generation Sequencing of 73 genes related to cardiac function was performed, incorporating PCR amplification, and any variants found were subjected to filtering for frequency and pathogenicity. Any variants suggested to be pathogenic were confirmed by Sanger sequencing afterwards.


      Variant listed as K542N, could be either CA389050168 or CA389050167.

      Variant: NP_000248.2:p.Lys542Asn

      ClinVar: N/A

      gnomAD: N/A


      MultipleGeneVariants:

      JUP Variant

      Variant: NM_002230.2:c.436G>A (p.Glu146Lys)

      CAID: CA8565496 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_002230.2:c.436G%3EA

      gnomAD: African 6.353e-5, Overall 2.030e-5 https://gnomad.broadinstitute.org/variant/17-39925702-C-T

    1. CaseMYH7-9: N/A

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: 1 other proband shares this genotype

      CaseGenotypingMethod: Testing for all 8 sarcomeric genes, plus GLA, LAMP2, and PRKAG2 was initiated in all probands. After the direct sequencing, the variants were filtered for pathogenicity and classified.

      Variant: NM_000257.3:c.1816G>A (p.Val606Met)

      ClinVar: 14091 https://www.ncbi.nlm.nih.gov/clinvar/variation/14091/

      gnomAD: European (Non-Finnish) 1.548e-5, Overall 7.070e-6 https://gnomad.broadinstitute.org/variant/14-23896866-C-T

    2. CaseMYH7-28: N/A

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CaseGenotypingMethod: Testing for all 8 sarcomeric genes, plus GLA, LAMP2, and PRKAG2 was initiated in all probands. After the direct sequencing, the variants were filtered for pathogenicity and classified.

      Variant: NM_000257.3:c.2782G>A (p.Asp928Asn)

      ClinVar: 164313 https://www.ncbi.nlm.nih.gov/clinvar/variation/164313/

      gnomAD: Not in gnomAD

    3. CaseMYH7-20: N/A

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CaseGenotypingMethod: Testing for all 8 sarcomeric genes, plus GLA, LAMP2, and PRKAG2 was initiated in all probands. After the direct sequencing, the variants were filtered for pathogenicity and classified.

      Variant: NM_000257.3:c.2945T>C (p.Met982Thr)

      ClinVar: 42941 https://www.ncbi.nlm.nih.gov/clinvar/variation/42941/

      gnomAD: European (Non-Finnish) 1.416e-3, Overall 8.484e-4 https://gnomad.broadinstitute.org/variant/14-23892910-A-G

    4. CaseMYH7-31: N/A

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CaseGenotypingMethod: Testing for all 8 sarcomeric genes, plus GLA, LAMP2, and PRKAG2 was initiated in all probands. After the direct sequencing, the variants were filtered for pathogenicity and classified.

      Variant: NM_000257.3:c.788T>C (p.Ile263Thr)

      ClinVar: 43106 https://www.ncbi.nlm.nih.gov/clinvar/variation/43106/

      gnomAD: European (Non-Finnish) 8.792e-6, Overall 3.977e-6 https://gnomad.broadinstitute.org/variant/14-23900635-A-G

    1. Here, we report detailed biochemical characterization and mechanochemical cycle modeling of recombinant human β-cardiac myosin motor domains carrying five DCM mutations

      DiseaseAssertion: DCM

      Variant1: NM_000257.3(MYH7):c.602T>C (p.Ile201Thr)

      ClinVar: 43093, https://www.ncbi.nlm.nih.gov/clinvar/variation/43093/

      gnomAD: n/a

      Variant2: NM_000257.3(MYH7):c.667G>A (p.Ala223Thr)

      ClinVar: 14112, https://www.ncbi.nlm.nih.gov/clinvar/variation/14112/

      gnomAD: 0.000003976, https://gnomad.broadinstitute.org/variant/14-23900859-C-T

      Variant3: NM_000257.3(MYH7):c.709C>T (p.Arg237Trp)

      ClinVar: 43098, https://www.ncbi.nlm.nih.gov/clinvar/variation/43098/

      gnomAD: 0.00001193, https://gnomad.broadinstitute.org/variant/14-23900817-G-A

      Variant4: NM_000257.3(MYH7):c.1594T>C (p.Ser532Pro)

      ClinVar: 14108, https://www.ncbi.nlm.nih.gov/clinvar/variation/14108/

      gnomAD: n/a

      Variant5: NM_000257.3(MYH7):c.2292C>G (p.Phe764Leu)

      ClinVar: 14109, https://www.ncbi.nlm.nih.gov/clinvar/variation/14109/

      gnomAD: n/a

    1. HCM085

      CaseHCM085: 49 yrs report, Vietnam, Asian

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001712, HP:0002875, HP:0011103, HP:0031295, HP:0001653, HP:0001279 (Left ventricular hypertrophy, Exertional dyspnea, Abnormality of the left ventricular outflow tract, Left atrial enlargement, Mitral regurgitation, Syncope)

      HPOsFreeText: Maximal LV thickness 19 mm

      CaseNotHPOs: HP:0005110, HP:0001297, HP:0004756 (Atrial fibrillation, Stroke, Ventricular tachycardia)

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: The gene panel included 10 sarcomeric genes (MYH7, MYBPC3, TNNT2, TNNI3, TPM1, MYL2, MYL3, ACTC1, TNNC1, MYH6), 9 genes encoding Z-disk components and Ca2+ homeostasis factors (LDB3, CSRP3, TCAP, VCL, ACTN2, MYOZ2, NEXN, JPH2, PLN), and 4 genes involved in HCM phenocopies (GLA, LAMP2, PRKAG2, TTR), All probands had left ventricular wall thickness >= 15 mm and no other diseases that can cause secondary hypertrophy

      CaseGenotypingMethod: The coding region, flanking sequences, and untranslated regions of each gene were enriched by LC-PCR, amplified, and sequenced on the Illumina MiSeq or MiniSeq platform. Identified variants were then filtered for pathogenicity and confirmed by Sanger sequencing.

      Variant: NM_000257.4(MYH7):c.1750G>A (p.Gly584Ser)

      ClinVar: 42862 https://www.ncbi.nlm.nih.gov/clinvar/variation/42862/

      gnomAD: Not in gnomAD

    1. 3

      Case3: Male, 53 yrs diagnosis, Portugal

      DiseaseAssertion: Dilated Cardiomyopathy

      FamilyInfo: No family history

      CasePresentingHPOs: HP:0001644, HP:0001635, HP:0011675, HP:0011713, HP:0012665, HP:0031192 (Dilated cardiomyopathy, Congestive heart failure, Arrhythmia, Left bundle branch block, Moderately reduced ejection fraction, Abnormal morphology of left ventricular trabeculae)

      HPOsFreeText: Left ventricular end-diastolic diameter of 56 mm

      CaseNotHPOs: HP:0002540, HP:0011706, HP:0001709, HP:0006682 (Inability to walk, Second degree atrioventricular block, Third degree atrioventricular block, Premature ventricular contractions)

      NotHPOsFreeText: N/A

      CasePreviousTesting: Proband has been studied before as part of FATIMA with general clinical assessment and cardiological investigations as well as exclusion criteria subject there. Tested genes include: LMNA, MYH7, MYBPC3, TNNT2, ACTA1, TPM1, CSRP3, TCAP, SGCD, PLN, MYL2, MYL3, TNNI3, TAZ, LDB3.

      CaseGenotypingMethod: Blood samples were obtained and NGS was performed on a panel of 15 different genes covering the coding sequence and flanking exon/intron boundaries. Sanger sequencing was used to validate the variants and provide additional coverage. Variants were interpreted and filtered for pathogenicity.

      CaseAddInfo: More info in 19044174 but paper is unavailable at this time

      Variant: NM_000257.3:c.5623G>T (p.Val1875Phe)

      CAID: CA389034842 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000257.3%3Ac.5623G%3ET

      gnomAD: Not in gnomAD

    1. identified in a 29 years old male DCM patient

      Case#: A 29 years old male DCM patient

      DiseaseAssertion:Familial dilated cardiomyopathy (FDCM), associated with the TNNT2 gene missense variant p.Arg144Trp (R144W)

      FamilyInfo: Family members had revealed its presence in three other individuals with DCM. A history of sudden cardiac deaths (SCD) in the family. Two individuals in the family, who were diagnosed with DCM, had died due to severe congestive heart failure at the age of 45 and 25 years. However, a 66-year-old individual in the same family with DCM having mild symptoms.

      ParentalTesting:NR

      CasePresentingHPOs: HP:0001644, HP:4000141, HP:0012664, HP:0004308, HP:0012828, HP:0001653

      CaseHPOFreeText: Dilated cardiomyopathy with left ventricular dilation, Age of onset, 25, left ventricular internal diastolic dimension of 72mm, reduced ejection fraction of 26%, has Ventricular arrhythmia, severe mitral regurgitation.

      CaseNotHPOs:NR

      CaseNotHPOFreeText: NR

      CasePreviousTesting:NR

      Genotyping Method: Used PCR with GenBank No. NM_000364, then followed by mutation subsequent screening analysis

      FunctionalAnalysis:The R144W mutation was found to be within the tropomyosin-binding domain of cTnT and alters the charge of the residue, so it is expected to have a significant impact on the structure and function of the protein. The novel unique/private R144W mutation identified in our present study is associated with FDCM

      Variant:NM_001276345.2:c.445C>T

      ClinVar:43640

      CAID:CA004505

      gnomAD: gnomAD v2: 1:201333470 G / A https://gnomad.broadinstitute.org/variant/1-201333470-G-A?dataset=gnomad_r2_1 gnomAD v4: chr1-201364342-G-A https://gnomad.broadinstitute.org/variant/chr1-201364342-G-A?dataset=gnomad_r4

      AdditionalInfo:25 bp deletion was found to be associated with both HCM and DCM in India and south Asia

    1. The patient is a 43 year old Caucasian female,

      Case1: 43 year old Caucasian female

      DiseaseAssertion: LVHT, mild distal myopathy

      FamilyInfo: LVHT was absent in all other family members who had undergone echocardiography, same MYH7 mutation detected in mother, who manifested with a mild distal myopathy

      CasePresentingHPOs: HP:0001962, HP:0001279, HP:0004756, HP:0004308, HP:0012391

      "Palpitations, Syncope, Ventricular tachycardia, Ventricular arrhythmia, Hyporeflexia of upper limbs"

      CaseHPOFreeText: ectopic atrial tachycardia, mild weakness for foot extension on the right side, reduced Achilles tendon reflexes

      CaseNotHPOs: n/a

      CaseNotHPOFreeText: n/a

      CasePreviousTesting: n/a

      GenotypingMethod: n/a

      Variant: NM_000257.4:c.5566G>A

      ClinVar: 190403

      CAID: CA347253

      gnomAD: https://gnomad.broadinstitute.org/variant/14-23883305-C-T

      0.000008795 European (non-Finnish)

    1. Medical Examiner's Case of Sudden Death in an Adolescent Female

      Case1: deceased 16 year old female

      DiseaseAssertion: HCM

      FamilyInfo: 6 additional family members were found to be at risk for HCM

      CasePresentingHPOs: HP:0001640, HP:0031319, HP:0002181

      "Cardiomegaly, Cardiomyocyte hypertrophy, Cerebral edema

      CaseHPOFreeText: Moderately enlarged heart, myocyte disarray, mild interstitial fibrosis

      CaseNotHPOs: n/a

      CaseNotHPOFreeText: n/a

      CasePreviousTesting: n/a

      GenotypingMethod: Whole Exome Next-Generation DNA Sequencing

      Variant: NM_000257.4:c.746G>A

      ClinVar: 14088

      CAID: CA016781

      gnomAD: not found

    1. 8

      Case8: Female, 12 yrs onset, Slovakia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: Affected family members

      CasePresentingHPOs: HP:0001639 (Hypertrophic Cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: Normal LV ejection fraction

      CasePreviousTesting: ABCC9, ACTC1, ACTN2, ANKRD1, CASQ2, CAV3, CRYAB, CSRP3, CTF1, DES, DSC2, DSG2, DSP, DTNA, EMD, FHL2, GLA, JUP, LAMA4, LAMP2, LDB3, LMNA, MYBPC3, MYH6, MYH7, MYL2, MYL3, MYLK2, MYOZ2, NEXN, PKP2, PLN, PRKAG2, RBM20, RYR2, SGCD, TAZ, TCAP, TMEM43, TNNC1, TNNI3, TNNT2, TPM1, TTN, TTR, VCL were all tested on NGS panel

      CaseGenotypingMethod: Genomic DNA was extracted from whole blood and samples were purified and amplified. The coding exons for the above genes were enriched and sequenced. The resulting variants were analyzed and filtered for predicted pathogenicity.

      CaseAddInfo: N/A

      Variant: NM_000257.4(MYH7):c.746G>A (p.Arg249Gln)

      ClinVar: 14088 https://www.ncbi.nlm.nih.gov/clinvar/variation/14088/

      gnomAD: Not in gnomAD

      MultipleGeneVariants

      (1) DSP Variant

      Variant: NM_004415.4(DSP):c.484C>G (p.Arg162Gly)

      ClinVar: 546994 https://www.ncbi.nlm.nih.gov/clinvar/variation/546994/

      gnomAD: 0.00006152, http://gnomad.broadinstitute.org/variant/6-7559520-C-G

    1. 18

      Case#: Subject number 18, female, 40 years (diagnosis), 65 years (baseline visit), 64 years (ERT)

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001324 (Muscle Weakness)

      CaseHPOFreeText:

      CaseNotHPOs: HP:0003236 (Elevated circulating creatine kinase concentration), HP:0002870 (obstructive sleep apnea), HP:0002098 (respiratory distress)

      CaseNotHPOFreeText: no mechanical ventilation at Baseline Visit, no mechanical ventilation at last visit

      CasePreviousTesting: "reduced enzymatic activity on fibroblasts, blood leukocytes or skeletal muscle and/or the presence of two known mutations in the GAA gene"

      PreviouslyPublished: N/A

    1. 22

      Case#: Subject number 22(L)

      DiseaseAssertion: Late Onset Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: N/A

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: CK testing: 265 U/L (60-305 U/L is normal), AST: 92 U/L (22-71 U/L is normal), ALT: 46 U/L (7-50 U/L is normal), Hex4: 5.9 mmol/mol Creatinine (≤20 mmol/mol Creatinine is normal), BNP 81.5 pg/mL (0.0–100.0 pg/mL is normal)

      glucosidase activity: GAA activity #1 was 1.07 micromole/L/h and GAA activity #2 (NBS) 0.92 in dried blood spots (>2.10 micromole/L/h is normal). 1.60 in confirmatory testing (>3.88 is normal).

      Variant 1: NM_000152.5(GAA):c.-32-13T>G

      Variant 1 ClinVarID: 4027

      Variant 1 CAid: CA116606

      Variant 2: NM_000152.5(GAA):c.-32-13T>G

      Variant 2 ClinVarID: 4027

      Variant 2 CAid: CA116606

      Zygosity: homozygous

      ParentalGenotype: N/A

      PreviouslyPublished: N/A

    2. 2

      Case#: Subject number 2(I), male, 10 days (start of ERT)

      DiseaseAssertion: Infantile Onset Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0200128 (biventricular hypertrophy), HP:0005165 (shortened PR interval), HP:0030234 (Highly elevated creatine kinase), HP:0001270 (motor delay)

      CaseHPOFreeText: severe septal left ventricular hypertrophy and mildly hypertrophied right ventricle. CRIM positive.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: CK testing: 846 U/L (60–305 U/L is normal), AST: 189 U/L (30–100 U/L is normal), ALT: 91 U/L (7-50 U/L is normal), BNP: 1232.5 pg/mL (0.0–100.0 pg/mL), Hex4: 30.2 mmol/mol Creatinine (≤20 mmol/mol Creatinine is normal)

      glucosidase activity: GAA activity #1 was 0.65 micromole/L/h and GAA activity #2 (NBS) 0.34 in dried blood spots (>2.10 micromole/L/h is normal). 0.4 in confirmatory testing (<3.88 is normal).

      Variant 1: NM_000152.5(GAA):c.525delT

      Variant 1 ClinVarID: 4033

      Variant 1 CAid: CA220406

      Variant 2: NM_000152.5(GAA):c.1694_1697delTCTC

      Variant 2 ClinVarID: N/A

      Variant 2 CAid: CA658795263

      Zygosity: Compound heterozygous

      ParentalGenotype: N/A

      PreviouslyPublished: N/A

    3. 25

      Case#: Subject number 25(L)

      DiseaseAssertion: Late Onset Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: N/A

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      glucosidase activity: GAA activity #2 (NBS) 0.95 in dried blood spots (>2.10 micromole/L/h is normal).

      Variant 1: NM_000152.5(GAA):c.2238G>C

      Variant 1 ClinVarID: 265160

      Variant 1 CAid: CA8815665

      Variant 2: NM_000152.5(GAA):c.2238G>C

      Variant 2 ClinVarID: 265160

      Variant 2 CAid: CA8815665

      Zygosity: homozygous

      ParentalGenotype: N/A

      PreviouslyPublished: N/A

    1. Patient 2

      Case#: Patient 2, male, symptoms noticed at 5 months

      DiseaseAssertion: Pompe Disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639, HP:0001324 (hypertrophic cardiomyopathy, muscle weakness)

      CaseHPOFreeText: Inability to swallow (needed NGT feeding until 21 months old)

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: <1% normal GAA expression in fibroblast; after ERT treatment had 100% enzyme activity in cell lysates; unclear how patient was diagnosed

      Variant 1: NM_000152.5:c.525delT

      Variant 1 ClinVarID: 4033

      Variant 1 CAid: CA220406

      Variant 2: NM_000152.5:c.525delT

      Variant 2 ClinVarID: 4033

      Variant 2 CAid: CA220406

      ParentalGenotype: Not provided

    1. #1

      Case#: Subject number 1, male, 0 years (report)

      DiseaseAssertion: Pompe disease

      FamilyInfo: Family member with PD

      CasePresentingHPOs: HP:0001638 (cardiomyopathy)

      CaseHPOFreeText:

      CaseNotHPOs: HP:0002153 (hyperkalemia), HP:0001324 (muscle weakness), HP:0003546 (Exercise intolerance), HP:0001252 (Hypotonia), HP:0003326 (Myalgia), HP:0002015 (dysphagia), HP:0002098 (respiratory distress), HP:0002094 (dyspnoea)

      CaseNotHPOFreeText: not asymptomatic, no biopsy

      CasePreviousTesting: "Enzymatic activity was detected by fluorometric techniques" "The GAA sequence was performed in all patients whose enzyme activity measured in DBS and lymphocytes was decreased."

      glucosidase activity: GAA activity was 0.5 mol/Lh in dried blood spots (normal range >0.75).

      Variant 1: NM_000152.5(GAA):c.236_246delCCACACAGTGC (p.Pro79ArgfsTer13)

      Variant 1 ClinVarID: 371302

      Variant 1 CAid: CA16041880

      Variant 2: NM_000152.5(GAA):c.236_246delCCACACAGTGC (p.Pro79ArgfsTer13)

      Variant 2 ClinVarID: 371302

      Variant 2 CAid: CA16041880

      Zygosity: homozygous

      ParentalGenotype: "the clinical information refers to parents as carriers of the disease, but the genetic study of his parents was not sent to us."

      PreviouslyPublished: N/A

    1. PD20

      Patient20: Female, Northern China

      CasePresentingHPOs:

      HPOsFreeText: IOPD

      CaseNotHPOs:

      NotHPOsFreeText:

      CaseAddInfo:

      CasePMIDs:

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant1: NM_000152.4(GAA):c.1320_1322del (p.Met440del)

      ClinVar: 526518, https://www.ncbi.nlm.nih.gov/clinvar/variation/526518/

      gnomAD: n/a

      Variant2: NM_000152.4(GAA):c.2560C>T (p.Arg854Ter)

      ClinVar: 4034, https://www.ncbi.nlm.nih.gov/clinvar/variation/4034/

      gnomAD: 0.0002146, http://exac.broadinstitute.org/variant/17-78092070-C-T

    2. PD08

      Patient8: Male, Southern China

      CasePresentingHPOs:

      HPOsFreeText: IOPD

      CaseNotHPOs:

      NotHPOsFreeText:

      CaseAddInfo:

      CasePMIDs:

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant1: NM_000152.4(GAA):c.1411_1414delGAGA (p.Glu471Profs)

      ClinVar: 188874, https://www.ncbi.nlm.nih.gov/clinvar/variation/188874/

      gnomAD: 1.688e-05, http://exac.broadinstitute.org/variant/17-78083827-CGAGA-C

    1. c.2481+102_2646+31del (p.Gly828_Asn882del)

      Case37

      HPOsFreeText: See Group Phenotypes


      CasePreviousTesting: Sanger sequencing

      CaseMethod1: Sanger sequencing and PCR Amplification

      CaseMethod2: Whole Exome Sequencing (WES)

      CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.


      Variant1: NM_000152.4:c.2481+102_2646+31del (p.Gly828_Asn882del) (exon 18 del)

      ClinVar: 4031 https://www.ncbi.nlm.nih.gov/clinvar/variation/4031/

      gnomAD: Not in gnomAD


      Variant2: NM_000152.4:c.1210G>A (p.Asp404Asn)

      CAID: CA8815234 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.1210G%3EA

      gnomAD: African 6.318e-5, Overall 3.223e-5 http://gnomad.broadinstitute.org/variant/17-78082511-G-A


      CaseAddInfo: Infantile Onset Pompe Disease

    2. c.1827delC(p.Tyr609*)

      Case66

      HPOsFreeText: See Group Phenotypes


      CasePreviousTesting: Sanger sequencing

      CaseMethod1: Sanger sequencing and PCR Amplification

      CaseMethod2: Whole Exome Sequencing (WES)

      CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.


      Variant1: NM_000152.4:c.1827delC (p.Tyr609*)

      ClinVar: 188936 https://www.ncbi.nlm.nih.gov/clinvar/variation/188936/

      gnomAD: European (Non-Finnish) 7.181e-5, Overall 3.260e-5 http://gnomad.broadinstitute.org/variant/17-78086448-AC-A


      Variant2: NM_000152.4:c.-32-13T>G

      ClinVar: 4027 https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G


      CaseAddInfo: Adult Late Onset Pompe Disease

    3. c.1209delC(p.Asp531Glyfs*37)

      Case3

      HPOsFreeText: See Group Phenotypes


      CasePreviousTesting: Sanger sequencing

      CaseMethod1: Sanger sequencing and PCR Amplification

      CaseMethod2: Whole Exome Sequencing (WES)

      CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.


      Variant: NM_000152.4:c.1209delC (p.Asp531Glyfs*37)

      CAID: CA658795247 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.1209delC

      gnomAD: Not in gnomAD


      CaseAddInfo: Infantile Onset Pompe Disease, Patient is homozygous for this variant

    4. c.546+2_5deltggg

      Case7

      HPOsFreeText: See Group Phenotypes


      CasePreviousTesting: Sanger sequencing

      CaseMethod1: Sanger sequencing and PCR Amplification

      CaseMethod2: Whole Exome Sequencing (WES)

      CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.


      Variant1: NM_000152.4:c.546+2_5delTGGG

      CAID: CA502402612 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.546%2B2_546%2B5delTGGG

      gnomAD: European (Non-Finnish) 9.395e-6, Overall 4.224e-6 http://gnomad.broadinstitute.org/variant/17-78078930-CGGTG-C


      Variant2: NM_000152.4:c.2501_2502delCA (p.Thr834Argfs*49)

      ClinVar: 286229 https://www.ncbi.nlm.nih.gov/clinvar/variation/286229/

      gnomAD: Latino 5.794e-5, Overall 7.994e-6 http://gnomad.broadinstitute.org/variant/17-78092008-CCA-C


      CaseAddInfo: Infantile Onset Pompe Disease

    5. c.1880C > T(p.Ser627Phe)

      Case68

      HPOsFreeText: See Group Phenotypes


      CasePreviousTesting: Sanger sequencing

      CaseMethod1: Sanger sequencing and PCR Amplification

      CaseMethod2: Whole Exome Sequencing (WES)

      CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.


      Variant1: NM_000152.4:c.1880C>T (p.Ser627Phe)

      CAID: CA294896504 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.1880C%3ET

      gnomAD: Not in gnomAD


      Variant2: NM_000152.4:c.-32-13T>G

      ClinVar: 4027 https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G


      CaseAddInfo: Adult Late Onset Pompe Disease

    6. c.2815_2816delGT(p.Val939fs*78)

      Case43

      HPOsFreeText: See Group Phenotypes


      CasePreviousTesting: Sanger sequencing

      CaseMethod1: Sanger sequencing and PCR Amplification

      CaseMethod2: Whole Exome Sequencing (WES)

      CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.


      Variant1: NM_000152.4:c.2815_2816delGT (p.Val939fs*78)

      ClinVar: 371481 https://www.ncbi.nlm.nih.gov/clinvar/variation/371481/

      gnomAD: East Asian 1.631e-4, Overall 1.194e-5 http://gnomad.broadinstitute.org/variant/17-78093082-CTG-C


      Variant2: NM_000152.4:c.1935C>A (p.Asp645Glu)

      CAID: 4029 https://www.ncbi.nlm.nih.gov/clinvar/variation/4029/

      gnomAD: East Asian 1.729e-3, Overall 1.240e-4 http://gnomad.broadinstitute.org/variant/17-78086721-C-A


      CaseAddInfo: Infantile Onset Pompe Disease

    7. c.1437+2T > C

      Case54

      HPOsFreeText: See Group Phenotypes


      CasePreviousTesting: Sanger sequencing

      CaseMethod1: Sanger sequencing and PCR Amplification

      CaseMethod2: Whole Exome Sequencing (WES)

      CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.


      Variant1: NM_000152.4:c.1437+2T>C

      CAID: CA401366685 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.1437%2B2T%3EC

      gnomAD: Not in gnomAD


      Variant2: NM_000152.4:c.-32-13T>G

      ClinVar: 4027 https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G


      CaseAddInfo: Juvenile Late Onset Pompe Disease

    8. c.722_723delTT(p.Phe241Cysfs*88)

      Case25

      HPOsFreeText: See Group Phenotypes


      CasePreviousTesting: Sanger sequencing

      CaseMethod1: Sanger sequencing and PCR Amplification

      CaseMethod2: Whole Exome Sequencing (WES)

      CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.


      Variant1: NM_000152.4:c.722_723delTT (p.Phe241Cysfs*88)

      CAID: CA658795235 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.722_723delTT

      gnomAD: Not in gnomAD


      Variant2: NM_000152.4:c.1687C>T (p.Gln563*)

      ClinVar: 370357 https://www.ncbi.nlm.nih.gov/clinvar/variation/370357/

      gnomAD: Not in gnomAD


      CaseAddInfo: Infantile Onset Pompe Disease

    9. c.525delT(p.Glu176Argfs*45)

      Case79

      HPOsFreeText: See Group Phenotypes


      CasePreviousTesting: Sanger sequencing

      CaseMethod1: Sanger sequencing and PCR Amplification

      CaseMethod2: Whole Exome Sequencing (WES)

      CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.


      Variant1: NM_000152.4:c.525delT (p.Glu176Argfs*45)

      ClinVar: 4033 https://www.ncbi.nlm.nih.gov/clinvar/variation/4033/

      gnomAD: European (Non-Finnish) 1.880e-4, Overall 9.959e-5 http://gnomad.broadinstitute.org/variant/17-78078909-CT-C


      Variant2: NM_000152.4:c.-32-13T>G

      ClinVar: 4027 https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G


      CaseAddInfo: Adult Late Onset Pompe Disease, 3 other patients have the same genotype

    10. c.2560C > T(p.Arg854*)

      Case23

      HPOsFreeText: See Group Phenotypes


      CasePreviousTesting: Sanger sequencing

      CaseMethod1: Sanger sequencing and PCR Amplification

      CaseMethod2: Whole Exome Sequencing (WES)

      CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.


      Variant1: NM_000152.4:c.2560C>T (p.Arg854*)

      ClinVar: 4034 https://www.ncbi.nlm.nih.gov/clinvar/variation/4034/

      gnomAD: African 1.891e-3, Overall 2.090e-4 http://gnomad.broadinstitute.org/variant/17-78092070-C-T


      Variant2: NM_000152.4:c.2236T>C (p.Trp746Arg)

      ClinVar: 499293 https://www.ncbi.nlm.nih.gov/clinvar/variation/499293/

      gnomAD: Not in gnomAD


      CaseAddInfo: Infantile Onset Pompe Disease

    1. 3/F

      Patient3: female

      CasePresentingHPOs: HP:0001270, HP:0001371

      HPOsFreeText: CRIM positive, partial heart normalization

      CaseNotHPOs: HP:0004887, HP:0025156

      NotHPOsFreeText: infusion associate reaction

      CaseAddInfo: symptom onset at 1yo, diagnosis and ERT at 5yo. Died due to failure to respond to ERT.

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant 1-3 in cis

      Variant1: NM_000152.3:c.1833_1839del

      CAID: CA913184757, http://reg.clinicalgenome.org/redmine/projects/registry/gene_indel

      gnomAD: n/a

      Variant2: NM_000152.3:c.1846G>T

      CAID: CA401369607, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA401369607

      gnomAD: n/a

      Variant3: NM_000152.3:c.1847_1848insT

      CAID: CA913184758, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA913184758

      gnomAD: n/a

      Variant4: NM_000152.4(GAA):c.1124G>T (p.Arg375Leu)

      ClinVar: 283230, https://www.ncbi.nlm.nih.gov/clinvar/variation/283230/

      gnomAD: 8.561e-06, http://exac.broadinstitute.org/variant/17-78082336-G-T

    2. 9/M

      Patient9: male

      CasePresentingHPOs: HP:0001270

      HPOsFreeText: CRIM negative, Anti-rh GGA antibodies maximum titer = 1:102.400, able to sit independently, partial heart normalization

      CaseNotHPOs: HP:0004887, HP:0025156, HP:0001371

      NotHPOsFreeText: infusion associated reaction

      CaseAddInfo: homozygous variants in trans, symptom onset at birth, diagnosis at 5 days, ERT at 1 year. Died due to cardiorespiratory failure.

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant1: NM_000152.3:c.1497G>A

      CAID: CA401367008, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA401367008

      gnomAD: n/a

    1. all 74 patients with finally confirmed Pompe

      GroupPresentingHPOs: HP:0003701, HP:0003327, HP:0003325, HP:0003236

      HPOsFreeText: average GAA activity with inhibitor of 0.18 nmol/punch × 21 hours

      GroupNotHPOs: n/a

      NotHPOsFreeText: n/a

      NumberMales: 32 (44%)

      NumberFemales: 42 (56%)

      CountryOrigin: n/a

      Ethnicity: n/a

      Race: n/a

      AgeRange: 18-81 years, median = 48 years

      TotalNumber: 74

      FamilyInfo: n/a

      NoFamily: n/a

      GroupPreviousTesting: DBS collected from peripheral vein analyzed with fluorometric assay

      GroupGenotypingMethod: Sanger sequencing of coding and exon flanking region of GAA gene

      Variant Count: 74

      Variant: NM_000152.4(GAA):c.-32-13T>G

      ClinVar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G

    1. 87

      Case#: 87, Gender N/A, 6 months old when diagnosed, Asian

      DiseaseAssertion:Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: N/A

      CaseHPOFreeText:N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: The patient did not present any symptoms, diagnosed was made based on the predicted impact of the variant by PolyPhen-2

      CasePreviousTesting: The GAA gene was sequenced using NGS and resequenced for confirmation using Sanger.

      Dried Blood spot test found an GAA activity of 4.6 pmol/h/disk with a reference value of 6.5 pmol/h/disk

      enzyme activity in fibroblast was recorded to be 5.4 nmol/h/mg protein.

      Variants: Variant1: (Two mutated alleles with heterozygous mutations)

      Variant1.1: NM_000152.5(GAA):c.752C>T (p.Ser251Leu)

      ClinVar: 346310

      CAID: CA8815007

      gnomAD: Highest population MAF = 0.002234 (East Asian)

      Variant1.2: NM_000152.5(GAA):c.761C>T (p.Ser254Leu)

      ClinVar: 330447

      CAID: CA8815009

      gnomAD: Highest popu;ation MAF= 0.002235 (East Asians)

      Variant2: NM_000152.5(GAA):c.2003A>G (p.Tyr668Cys)

      ClinVar: 546808

      CAID: N/A

      gnomAD: N/A

      ParentalGenotype:N/A

      PreviouslyPublished:N/A

    1. CaseIP2-9: Male, Taiwan, Birth diagnosis

      HPOsFreeText: GAA (MS/MS) enzyme activity at 0.09 umol/hr/L, Serum CK at 483 U/L

      GenotypingMethod: GAA Gene Sequencing and PCR Amplification


      Variant1: NM_000152.4:c.1935C>A (p.Asp645Glu)

      ClinVar: 4029 https://www.ncbi.nlm.nih.gov/clinvar/variation/4029/

      gnomAD: East Asian 1.729e-3, Overall 1.240e-4 http://gnomad.broadinstitute.org/variant/17-78086721-C-A


      Variant2: NM_000152.4:c.1726G>A (p.Gly576Ser)

      ClinVar: 92467 https://www.ncbi.nlm.nih.gov/clinvar/variation/92467/

      gnomAD: East Asian 0.1427, Overall 0.01700 http://gnomad.broadinstitute.org/variant/17-78085871-G-A


      Variant3: NM_000152.4:c.2274dup (p.Gly759Argfs*?)

      CAID: CA658795280 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.2273_2274insC

      gnomAD: Not in gnomAD


      CaseAddInfo: Infantile Onset Pompe Disease, Nomenclature indicates that Variant 1 and 2 are in cis

    2. CaseIP-4: Male, Taiwan, Birth diagnosis

      HPOsFreeText: 4MU enzyme activity at 0.45, MS/MS ennzyme activity at 0.09

      GenotypingMethod: GAA Gene Sequencing and PCR Amplification


      Variant1: NM_000152.4:c.1726G>A (p.Gly576Ser)

      ClinVar: 92467 https://www.ncbi.nlm.nih.gov/clinvar/variation/92467/

      gnomAD: East Asian 0.1427, Overall 0.01700 http://gnomad.broadinstitute.org/variant/17-78085871-G-A


      Variant2: NM_000152.4:c.1935C>A (p.Asp645Glu)

      ClinVar: 4029 https://www.ncbi.nlm.nih.gov/clinvar/variation/4029/

      gnomAD: East Asian 1.729e-3, Overall 1.240e-4 http://gnomad.broadinstitute.org/variant/17-78086721-C-A


      Variant in literature as c.2274insC, however investigation revealed it was primarily a duplication.

      Variant3: NM_000152.4:c.2274dup (p.Gly759Argfs*?)

      CAID: CA658795280 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.2273dupC

      gnomAD: Not in gnomAD


      CaseAddInfo: Infantile Onset Pompe Disease, Nomenclature indicates Variant 1 and 2 are in cis

    3. CaseOPOPD-1: Male, Taiwan, Birth diagnosis

      HPOsFreeText: GAA (MS/MS) enzyme activity at 0.41 umol/hr/L

      GenotypingMethod: GAA Gene Sequencing and PCR Amplification


      Variant1: NM_000152.4:c.424_440del (p.Ser142Leufs*29)

      CAID: CA658795228 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.424_440del

      gnomAD: Not in gnomAD


      Variant2: NM_000152.4:c.1726G>A (p.Gly576Ser)

      ClinVar: 92467 https://www.ncbi.nlm.nih.gov/clinvar/variation/92467/

      gnomAD: East Asian 0.1427, Overall 0.01700 http://gnomad.broadinstitute.org/variant/17-78085871-G-A


      CaseAddInfo: One Pompe Mutation and One Pseudodeficency Mutation, 2 others have the same genotype

    4. CaseLP2-1: Female, Taiwan, Birth diagnosis

      HPOsFreeText: GAA (MS/MS) enzyme activity at 0.54 umol/hr/L, Serum CK at 72 U/L

      GenotypingMethod: GAA Gene Sequencing and PCR Amplification


      Variant1: NM_000152.4:c.424_440del17 (p.Ser142Leufs*29)

      CAID: CA658795228 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.424_440del17

      gnomAD: Not in gnomAD


      Variant2: NM_000152.4:c.1840A>G (p.Thr614Ala)

      CAID: CA401369588 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.1840A%3EG

      gnomAD: Not in gnomAD


      Variant3: NM_000152.4:c.2647-23delT

      ClinVar: 557403 https://www.ncbi.nlm.nih.gov/clinvar/variation/557403/

      gnomAD: East Asian 2.005e-3, Overall 1.432e-4 http://gnomad.broadinstitute.org/variant/17-78092425-CT-C


      CaseAddInfo: Late Onset Pompe Disease, Nomenclature indicates that Variant 2 and 3 are in cis

    1. 20 mg/kg (N = 16)

      Case19HPOsFreeText: 20 mg/kg GAA treatment, GAA activity at 8 pmol/spot/hr, GAA activity at 33% lower limit of normal

      CaseAddInfo: Late Onset Pompe Disease


      CaseGenotypingMethod: Method not described, only that the diagnosis was "confirmed … based on 2 GAA gene mutations"


      Variant1: NM_000152.4:c.-32-13T>G

      ClinVar: 4027 https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 https://gnomad.broadinstitute.org/variant/17-78078341-T-G


      Variant2: NM_000152.4:c.525delT (p.Glu176Argfs)

      ClinVar: 4033 https://www.ncbi.nlm.nih.gov/clinvar/variation/4033/

      gnomAD: European (Non-Finnish) 1.880e-4, Overall 9.959e-5 https://gnomad.broadinstitute.org/variant/17-78078909-CT-C


      CaseAddInfo:

    1. Case31: Female, 45 years report

      HPOsFreeText: ERT not started, 6 Minute Walking Test at 457 meters, Forced Vital Capacity at 99%

      GenotypingMethod: GAA Gene Sequencing


      Variant1: NM_000152.4:c.-32-13T>G

      ClinVar: 4027 http://www.ncbi.nlm.nih.gov/clinvar/variation/4027

      gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G


      Variant2: NM_000152.4:c.1636+1G>C

      CAID: CA401367398 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.1636%2B1G%3EC

      gnomAD: Not in gnomAD


      CaseAddInfo: Late Onset Pompe Disease

    2. Case1: Male, 69 years report

      HPOsFreeText: 8 years of ERT completed, 6 Minute Walking Test at 467 meters, Forced Vital Capacity at 61%

      GenotypingMethod: GAA Gene Sequencing


      Variant1: NM_000152.4:c.-32-13T>G

      ClinVar: 4027 http://www.ncbi.nlm.nih.gov/clinvar/variation/4027

      gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G


      Variant2: NM_000152.4:c.3G>A

      CAID: CA401359809 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.3G%3EA

      gnomAD: European (Non-Finnish) 8.945e-6, Overall 4.041e-6 http://gnomad.broadinstitute.org/variant/17-78078388-G-A


      CaseAddInfo: Late Onset Pompe Disease

    3. Case13: Female, 30 years report

      HPOsFreeText: 7 years of ERT completed, 6 Minute Walking Test at 520 meters, Forced Vital Capacity at 50%

      GenotypingMethod: GAA Gene Sequencing


      Variant1: NM_000152.4:c.-32-13T>G

      ClinVar: 4027 http://www.ncbi.nlm.nih.gov/clinvar/variation/4027

      gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G


      Variant2: NM_000152.4:c.525delT (p.Glu176Argfs*42)

      ClinVar: 4033 https://www.ncbi.nlm.nih.gov/clinvar/variation/4033/

      gnomAD: European (Non-Finnish) 1.880e-4, Overall 9.959e-5 http://gnomad.broadinstitute.org/variant/17-78078909-CT-C


      CaseAddInfo: Late Onset Pompe Disease

    4. Case36: Female, 69 years report

      HPOsFreeText: ERT not started, 6 Minute Walking Test at 252 meters, Forced Vital Capacity at 87%

      GenotypingMethod: GAA Gene Sequencing


      Variant1: NM_000152.4:c.-32-13T>G

      ClinVar: 4027 http://www.ncbi.nlm.nih.gov/clinvar/variation/4027

      gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G


      Variant2: NM_000152.4:c.854C>G (p.Pro285Arg)

      ClinVar: 225114 https://www.ncbi.nlm.nih.gov/clinvar/variation/225114/

      gnomAD: European (Non-Finnish) 1.148e-5, Overall 5.109e-6 http://gnomad.broadinstitute.org/variant/17-78081517-C-G


      CaseAddInfo: Late Onset Pompe Disease

    5. Case4: Male, 50 years report

      HPOsFreeText: 9 years of ERT completed, 6 Minute Walking Test at 140 meters, Forced Vital Capacity at 34%

      GenotypingMethod: GAA Gene Sequencing


      Variant1: NM_000152.4:c.-32-13T>G

      ClinVar: 4027 http://www.ncbi.nlm.nih.gov/clinvar/variation/4027

      gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G


      CaseAddInfo: Late Onset Pompe Disease, Variant is homozygous for this patient

    6. Case28: Female, 49 years report

      HPOsFreeText: 6 years of ERT completed, 6 Minute Walking Test at 251 meters, Forced Vital Capacity at 109%

      GenotypingMethod: GAA Gene Sequencing


      Variant1: NM_000152.4:c.-32-13T>G

      ClinVar: 4027 http://www.ncbi.nlm.nih.gov/clinvar/variation/4027

      gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G


      Variant2: NM_000152.4:c.799_803delinsA (p.Leu267Serfs)

      CAID: CA891862613 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.799_803delinsA

      gnomAD: Not in gnomAD


      CaseAddInfo: Late Onset Pompe Disease

    7. Case24: Female, 48 years report

      HPOsFreeText: 9 years of ERT completed, 6 Minute Walking Test at 180 meters, Forced Vital Capacity at 67%

      GenotypingMethod: GAA Gene Sequencing


      Variant1: NM_000152.4:c.-32-13T>G

      ClinVar: 4027 http://www.ncbi.nlm.nih.gov/clinvar/variation/4027

      gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G


      Variant2: NM_000152.4:c.2481+102_2646+31del (p.Gly828_Asn882del) (exon 18 del)

      ClinVar: 4031 https://www.ncbi.nlm.nih.gov/clinvar/variation/4031/

      gnomAD: Not in gnomAD


      CaseAddInfo: Late Onset Pompe Disease

    1. 7

      Case#: Patient 7, female

      CasePresentingHPOs: HP:0003236, HP:0003325

      CaseAddInfo: 53yo at onset, 55yo at diagnosis

      VariantAllele1: NM_000152.4(GAA):c.-32-13T>G

      ClinVar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G

      VariantAllele2: NM_000152.4(GAA):c.1927G>A (p.Gly643Arg)

      ClinVar: 4023, https://www.ncbi.nlm.nih.gov/clinvar/variation/4023/

      gnomAD: 5.884e-05, http://exac.broadinstitute.org/variant/17-78086713-G-A

    2. 13

      Case#: Patient 13, female

      CasePresentingHPOs: HP:0003236, HP:0003325

      CaseAddInfo: 28yo at onset, 48yo at diagnosis

      VariantAllele1: NM_000152.4(GAA):c.-32-13T>G

      ClinVar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G

      VariantAllele2: NM_000152.4(GAA):c.2189+1G>T

      ClinVar: 558223, https://www.ncbi.nlm.nih.gov/clinvar/variation/558223/

      gnomAD: n/a

    1. A male infant, with a gestational age of 37 weeks and 4 days and a birth weight of 3.640 kg, was transferred to our hospital with a diagnosis of HCM at 48 hours of life

      Case: male, gestational age of 37 weeks and 4 days, birth weight = 3.640kg

      CasePresentingHPOs: HP:0001639, HP:0030148, HP:0200128, HP:0001640, HP:0003236, HP:0002910, HP:0002788, HP:0001522, HP:0009051

      HPOsFreeText: ventricular septal thickness = 11mm, left ventricular posterior wall thickness = 8-9mm (higher at apical level), CK = 4168 UI/L, glutamic oxaloacetic transaminase = 250 UI/L, normal brain and abdominal ultrasounds, GAA activity = 0.9 μmol/L/h, CRIM positive, treated with ERT and beta-blockers, subsarcolemmal vacuolization of the cardiac muscle, moderate vacuoles in skeletal and smooth muscle, neurons, and glial cells due to glycogen accumulation

      CaseNotHPOs: HP:0006673, HP:0001941, HP:0001943

      CaseAddInfo: diagnosis of HCM at 48hrs of life, non consanguineous Nigerian parents, no family history of heart disease, admitted to hospital at 2 months due to upper respiratory infection, death due to ventricular fibrillation during central line placement procedure

      CasePreviousTesting: (2D) echocardiogram, EKG, laboratory tests, brain and abdominal ultrasounds, DBS

      CaseGenotypingMethod: n/a

      Variant: NM_000152.4(GAA):c.2560C>T (p.Arg854Ter)

      ClinVar: 4034, https://www.ncbi.nlm.nih.gov/clinvar/variation/4034/

      gnomAD: 0.0002146, http://exac.broadinstitute.org/variant/17-78092070-C-T

    1. later

      CaseB: Female, 2 months onset, 6 months diagnosis

      CasePresentingHPOs: HP:0001270, HP:0003324, HP:0002540, HP:0006532, HP:0003202, HP:0004887, HP:0001638 (Motor delay, Generalized weakness, Inability to walk, Pulmonary infection, Muscle atrophy, Respiratory failure requiring assisted ventilation, Cardiomyopathy)

      HPOsFreeText: CRIM positive, Has a tracheostoma, Needs ventilatory support for almost 24 h/day

      CaseNotHPOs: HP:0100543 (Cognitive impairment)

      CaseAddInfo: Infantile-Onset Pompe Disease

    1. 12

      Case#: Subject number 12, male, 63 years (report), 35 years (onset), 55 years (diagnosis)

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0009830 (peripheral neuropathy)

      CaseHPOFreeText: ambulatory, assistive device (cane, wheelchair)

      CaseNotHPOs: HP:0000360, HP:0002650, HP:0000939, HP:0000821, HP:0000365, HP:0002617, HP:0100647, HP:0010788, HP:0001638 (tinnitus, scoliosis, osteoporosis, hypothyroidism, hearing loss, aneurysm, Graves disease, Testicular cancer, cardiomyopathy)

      CaseNotHPOFreeText: no infusion reaction, no tracheostomy, not on BiPAP

      CasePreviousTesting: “documented deficiency of acid alpha-glucosidase enzyme activity”; on enzyme replacement therapy

      Variant 1: NM_000152.5(GAA):c.-32-13T>G (p.Tyr766Ser)

      Variant 1 ClinVarID: 4027

      Variant 1 CAid: CA116606

      Variant 2: NM_000152.5(GAA):c.1951_1952delGGinsT (p.Gly651SerfsTer?)

      Variant 2 ClinVarID: 633225

      Variant 2 CAid: CA913191010

      Zygosity: Compound heterozygous

      ParentalGenotype: N/A

      PreviouslyPublished: N/A

    1. LOPD-4

      CaseLOPD-4: 28 years diagnosis

      HPOsFreeText: GAA activity 3.4 (nmol · h−1 · mg−1), Mean percentage of normal 4.7%

      CaseNotHPOs: HP:0003236 (Increased serum CK)

      GenotypingMethod: Newborn Screening Panels


      Variant: NM_000152.4:c.-32-13T>G

      ClinVar: 4027 http://www.ncbi.nlm.nih.gov/clinvar/variation/4027

      gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G


      CaseAddInfo: Late Onset Pompe Disease, Patient is homozygous for the above variant

    2. PD/VOUS-6

      CasePD/VOUS-6: 2 weeks diagnosis

      HPOsFreeText: GAA activity 8.26 (nmol · h−1 · mg−1), Mean percentage of normal 11.6%

      GenotypingMethod: Newborn Screening Panels


      Variant1: NM_000152.4:c.1726G>A (p.Gly576Ser)

      ClinVar: 92467 https://www.ncbi.nlm.nih.gov/clinvar/variation/92467/

      gnomAD: East Asian 0.1427, Overall 0.01700 http://gnomad.broadinstitute.org/variant/17-78085871-G-A


      Variant2: NM_000152.4:c.2065G>A (p.Glu689Lys)

      ClinVar: 4030 https://www.ncbi.nlm.nih.gov/clinvar/variation/4030/

      gnomAD: East Asian 0.2355, Overall 0.05524 http://gnomad.broadinstitute.org/variant/17-78087041-G-A


      Variant3: NM_000152.4:c.2302C>T (p.Pro768Ser)

      CAID: CA401324897 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.3:c.2302C%3ET

      gnomAD: Not in gnomAD


      CaseAddInfo: Patient has one pseudodeficency allele and one allele of uncertain significance, Nomenclature claims Variant 1 and 2 are in cis

    1. Because of their greater efficiency in rescuing exon 2 splicing, we decided to test the effect of AMOs 1, 2, and 3 on cultured fibroblasts obtained from a patient carrying the c.-32-13T > G mutation in heterozygosis with an unknown mutation that abrogated the expression of the other allele.

      Patient1: the efficacy of AMOs 1, 2, and 3 were tested in cultured fibroblasts from this patient

      Under basal conditions, the fibroblasts retained 20% enzymatic activity compared to WT cells; treatment with combination of the AMOs showed rescue of normally spliced GAA mRNA, this was confirmed with real-time qPCR

      CasePresentingHPOs:

      HPOsFreeText:

      CaseNotHPOs:

      NotHPOsFreeText:

      CaseAddInfo:

      CasePMIDs:

      CasePreviousTesting: n/a

      CaseGenotypingMethod: n/a

      Variant1: NM_000152.4(GAA):c.-32-13T>G

      Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G

      Variant2: unknown

    1. 16

      Case#: P 16, Female, 3.4 months old when started ERT (Died at 27.0 months), German

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: P:0001639 , HP:0001252 , HP:0003701, HP:0002090

      (Hypertrophic cardiomyopathy, Muscular hypotonia, Proximal muscle weakness, Pneumonia)

      CaseHPOFreeText: Pneumonia, deterioration and AR III were complications during ERT)

      Ventilation and tube feeding were necessary

      Best motor status was sitting

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: CRIM status was positive

      Antibody titer 1:5,600

      Variant: NM_000152.5(GAA):c.1548G>A (p.Trp516Ter)

      ClinVar:<br /> 189025

      CAID: CA274281

      gnomAD: MAF=0.00001552 in European non-Finnish

      Variant: c.IVS14 + 20A>G (old nomenclature)

      ClinVar: N/A

      CAID: N/A

      gnomAD: N/A

      ParentalGenotype: The maternal allele carried the c.IVS14 + 20A>G variant

      The paternal allele carried the c.1548G>A Variant

      PreviouslyPublished: N/A

    1. 2

      Case#: Patient 2, Male, 2.5 months old at diagnosis, African Canadian

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001638, HP:0032988

      (Cardiomyopathy, Persistent head lag)

      CaseHPOFreeText: antigravity movements arms>legs

      Previous to ERT NG tube feeding was necessary due to aspiration, after ERT patient uses a GJ tube.

      Patient requires oxygen and BiPAP at night.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: Patient can bear its weight independently.

      CasePreviousTesting: No GAA measurement

      Variant: NM_000152.3:c.546+2T>C

      ClinVar: N/A Double check

      CAID: CA401361919

      gnomAD: N/A

      ParentalGenotype:N/A

      PreviouslyPublished:N/A

    2. 7

      Case#: Patient 7, Female, diagnosed at 3 months old (died at 15 months old), African American

      DiseaseAssertion: Pompe disease

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001638 (Cardiomyopathy)

      CaseHPOFreeText: Previous to ERT patient did not required oxygen support. Patient needed Invasive ventilation at week 38 ERT until death 2 months later.

      Previous to ERT and during it patient was unable to independently hold head or sit unsupported.

      Previous to ERT NG tube feeds at age 3 months due to aspiration. During ERT patient used a GJ tube

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      Variant: NM_000152.5(GAA):c.2560C>T (p.Arg854Ter)

      ClinVar: 4034

      CAID: CA340130

      gnomAD: Highest population MAF= 0.001891 (African)

      ParentalGenotype:N/A

      PreviouslyPublished: N/A

    1. Detailed characteristics of these patients

      Patient9: male, 10yo, juvenile onset

      CasePresentingHPOs:

      HPOsFreeText: LOPD, BMI = 14.7 / 15.2 / 15.8, WGMS = 0 / 0 / 0

      CaseNotHPOs: HP:0002355

      NotHPOsFreeText: did not require respiratory support

      CaseAddInfo:

      CasePMIDs:

      CasePreviousTesting: same as group

      CaseGenotypingMethod: same as group

      Variant1: NM_000152.4(GAA):c.-32-13T>G

      Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G

      Variant2: NM_000152.4(GAA):c.1561G>A (p.Glu521Lys)

      ClinVar: 4022, https://www.ncbi.nlm.nih.gov/clinvar/variation/4022/

      gnomAD: 0.000003980, http://gnomad.broadinstitute.org/variant/17-78084749-G-A

    1. 32

      Patient32: Male, Caucasian, first investigated at 15yo

      CasePresentingHPOs: HP:0003677, HP:0002111, HP:0002875, HP:0003458

      HPOsFreeText: CK < 10x increase, CK = 662 U/L. Reduced alpha-glucosidase activity.

      CaseNotHPOs: HP:0003325, HP:0002093

      CaseAddInfo: onset in childhood, confirmed Pompe Disease via Sanger Sequencing, 2 siblings also carried same variants and presented with reduced enzyme activity but were asymptomatic at time of study.

      CasePreviousTesting: same as group, muscle biopsy, EMG

      CaseGenotypingMethod: same as group

      Variant1: NM_000152.4(GAA):c.525delT (p.Glu176Argfs)

      ClinVar: 4033, https://www.ncbi.nlm.nih.gov/clinvar/variation/4033/

      gnomAD: 7.041e-05, http://exac.broadinstitute.org/variant/17-78078909-CT-C

      Variant2: NM_000152.4(GAA):c.-32-13T>G

      Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/

      gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G